Biophysical and biological effects from infrared Low-Level-Laser-Therapy by Joensen, Jon
Biophysical and biological effects from infrared 
Low-Level-Laser-Therapy
Jón Joensen
Dissertation for the degree philosophiae doctor (PhD)
at the University of Bergen
2013
Dissertation date: 15.08.13                   .
2 
 
SCIENTIFIC ENVIRONMENT
University of Bergen - Faculty of Medicine and Dentistry: 
o Physiotherapy Research Group, 
Department of Public Health and Primary Health Care.
o Department of Clinical Dentistry.
o Department of Biomedicine.
Bergen University College - Faculty of Health and Social Science:
o Department of Occupational Therapy, Physiotherapy and Radiography.
o NorPhyPain research group.
o Centre for Evidence-Based Practice.
Bergen University College - Faculty of Education:
o Department of Sport and Physical Activity.
Bergen University College – Faculty of Engineering:
o Department of Electrical Engineering.
University of São Paulo, Cidade Universitária, Brazil:
o Institute of Biomedical Sciences.
Leeds Metropolitan University, Leeds, United Kingdom:
o Faculty of Health.
3 
 
ACKNOWLEDGEMENT
There are many persons I wish to thank for their contribution to this thesis. First of all I will 
thank my supervisor, professor Jan Magnus Bjordal, for excellent guidance and support 
through my senior research fellowship. I am grateful to be inspired by your excitement of 
research within physiotherapy, and to benefit from your knowledge in the field of research 
and Low-Level-Laser-Therapy.
I will thank my wife Hanne and our three daughters: Maria, Katrina and Thea, for their 
continuous support and patience during these years where I in periods have worked 
intensively on papers and the thesis.
Thanks to the members of NorPhyPain research group for fruitful discussions, and to the 
staff at the Department of Physiotherapy, Bergen University College. A special thanks to 
physiotherapist Jan Henrik Demmink for several interesting discussions on research in 
physiotherapy, and for the collaboration on thermography in study I; and to physiotherapist 
Steinar Hummelsund for the collaboration on ultrasonography images in Study II and III.
Thanks to physiologist Vegard V. Iversen, professor Rolf K. Reed and Gerd Signe Salvesen 
at the Department of Biomedicine, University of Bergen, for the collaboration on the animal 
studies.
Thanks to Professor Nils Roar Gjerdet, Professor Anders Mølster and Odd Lundberg at 
Biomaterials, Department of Clinical Dentistry, University of Bergen, for the collaboration
on tendon tensile strength testing in study III, in addition to spending considerable time 
developing successful tendon grips.
Thanks to all co-authors on the three papers; in addition to those mention above I’ll thank 
Rodrigo Á. B. Lopes-Martins (Sao Paulo, Brazil), Mark I. Johnson (Leeds, UK) and Knut 
Øvsthus (Bergen, Norway).
Thanks to all volunteers in the study on thermography during LLLT irradiation.
This work was made possible through a scholarship as research fellow at the Department of 
Physiotherapy, Bergen University College. 
4 
 
ABSTRACT OF THE THESIS
INTRODUCTION
Physiotherapists have since the early days of the profession utilized electro physical agents 
(EPAs) as part of their intervention toolbox. A prerequisite for application of all EPAs is 
that the applied energy affects biological processes in the body tissue. Low level laser 
therapy (LLLT) has been used as an intervention for the last three decades to modulate 
processes in pathological tissue beneath the skin. However, the photoprotective property of 
the skin is a significant barrier to optical energy applied by LLLT devices. The irradiated 
electromagnetic energy from LLLT first interacts with the skin where biophysical processes 
occur. The penetrating part of the energy will then act as an active ingredient in biological 
processes in subcutaneous tissue. 
AIM
The overall aim of this Thesis was to investigate biophysical and biological effects from 
commercial infrared LLLT devices commonly used in clinical physiotherapy practice. 
METHODS
Study I was designed as a blinded placebo-controlled study of repeated measures. The 
thermal effects from different doses of irradiation from two infrared class 3B lasers was 
investigated in situ in human skin of different skin colours, age and genders. Study II was a 
basic research study of repeated measures design. The time-profile for energy penetration
through skin during 150 sec of irradiation from two infrared class 3B lasers was elucidated 
in vivo in rat skin. Study III was designed as a double-blind randomized controlled trial on
effect from a 3 J irradiation dose in situ/in vivo in acute rat Achilles tendons trauma.
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RESULTS
There was a positive correlation between increasing irradiation doses and increased skin 
temperature for both lasers in all groups of participants. The skin temperature increased 
significantly (p<0.01) more in dark skin during laser irradiation than in light skin, regardless 
of irradiated doses and laser type. There were no significant differences in skin temperature 
between genders or age groups during laser irradiation. 
The percentage of energy penetrating through rat skin from the Ȝ QPODVHUwas constant
(20%) during 150 seconds of exposure, while skin penetration from the Ȝ 904 nm laser
increased almost linearly (38%-58%) and by 50% during the 150 sec of irradiation. The 
percentage of energy penetrating through rat skin during irradiation was significantly 
(p<0.01) higher from the Ȝ 904 nm laser WKDQ IURP WKH Ȝ 810 nm laser at all measured 
time-points. 
The biological effect from 3 J half an hour after trauma was significant (p<0.05) increased 
tendon thickness (including the peritendon) in injured Achilles tendons compared to 
animal’s healthy Achilles tendon in the active-LLLT group. These tendon thickness 
differences were insignificant (p=0.35) in the placebo-LLLT group. There were no 
significant differences in UTS in any group.
CONCLUSIONS
This project has revealed that the biophysical properties of two common types of LLLT 
devices; O=810 nm and O=904 nm, yield significantly different thermal effects in human 
skin and possess significant different optical penetration abilities in rat skin. These 
biophysical properties of infrared class 3B lasers are of scientific value as no studies so far 
have dealt with these effects. These findings support the differentiation made in WALT 
dosage recommendations for these two types of lasers. The thermal effects in light and 
medium coloured skin were negligible (<1.5°C) for WALT recommended doses from both 
laser types, so were the thermal effects in dark skin from the O=904 nm, 60 mW MOP laser 
(<2°C). In contrast, the O=810 nm, 200 mW caused thermal effects (>9°C) above the pain 
threshold, and indicate that these LLLT devices parameters are probably unsuitable for 
clinical use in patients with dark skin.
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The project also revealed that LLLT irradiation can exacerbate the acute inflammatory 
process in terms of increased oedema formation. Possible explanations for this somewhat 
surprising finding include that half an hour may be too early to initiate LLLT after trauma, 
or that a recently LLLT-treated injured tendon may be more vulnerable than untreated 
tendons to a repeated injury, or simply that the dose was too high. Future studies are needed 
to determine these issues.
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ABBREVIATIONS
ANOVA Analysis of variance
°C degrees Celsius
CI confidence interval
cm centimetre (10-2 meter)
cm2 square centimetre
ECM extracellular matrix
EPAs Electro Physical Agents
g gram 
h Planck’s constant 
h = 6.626-34
Hz Hertz
J Joule
kHz kilo Hertz (103 Hertz)
Laser Light Amplification by
Stimulated Emission of 
Radiation
LED Light emission diodes
LLLT Low Level Laser Therapy
MOP Mean Output Power
mg milligram (10-3 gram)
mK milli Kelvin (10-3 Kelvin)
ml milliliter (10-3 litre)
mm millimeter
mW millewatt (10-3 Watt)
m micrometer (10-6)
n number in a sample
N Newton
NSAIDs Non-Steroidal Anti-
Inflammatory Drugs
nsec nanosecond (10-9 sec.)
nm nanometer (10-9 meters)
nW nanowatt (10-9 Watt)
p probability level
PDT Photodynamic therapy
PGE2 Prostaglandin-E2
RCTs Randomized Controlled 
Trials
RTUS Real Time 
Ultrasonography
sec second
SD Standard Deviation
UK United Kingdom
UTS Ultimate Tensile Strength
W Watt 
WALT World Association for 
Laser Therapy
Ȝ Wavelength designed by 
the Greek letter Lambda
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1. INTRODUCTION
1.1 A BRIEF HISTORICAL VIEW ON ELECTRO PHYSICAL AGENTS (EPAS) AND
PHYSIOTHERAPY
The first electrotherapy pioneers back in the 19th century were John Wesley and James 
Graham. They used electrical currents in the treatment of various health disorders from 
rheumatism and epilepsy to impotence. The first electrotherapy department at a 
hospital was started by Golding Bird at the Guy’s Hospital, London, in 1836 (Selcon, 
2001). Investigative reports on effects from physical modalities in musculoskeletal 
conditions were published as early as in 1931 in Journal of American Medical 
Association (Wolfson, 1931). The article concluded that “the result obtained by the 
combined therapy, is encouraging, in that quicker and often earlier recovery has 
been attained”. This sparked an interest in research on physical modalities and 
several papers were published just before and after World War II. Studies from this 
early period focused either on effects from electrical stimulation of the peripheral 
nervous system, or thermal stimuli delivered by hot baths, ultrasound, infrared heat 
lamps or ice packs (Pohlman et al., 1939; Schaubel, 1946; Gersten et al., 1949). The overriding 
hypothesis from this period was that heating induced by physical modalities would 
speed up metabolism and accelerate healing and restoration of damaged tissue (Kohn and 
Rollerson, 1959). One of the great challenges was to find out how the skin barrier affected 
the transfer of physical energy to the tissues beneath.
During the 1950’s, physiotherapists took an interest in further development of massage 
and manual techniques. Orthopaedic surgeon James Cyriax at  St. Thomas Hospital in 
London had great influence on the physiotherapy pioneers in manual therapy (Lamb et 
al., 2003). Friction massage, joint mobilization/manipulation and passive stretching were 
included in the repertoire of manual modalities. An important perspective in this 
development of the profession was that physiotherapists extended their scope of 
practice to include examination of patients. The pioneers of manual therapies 
developed an extensive examination system and advocated that treatment decisions 
should be based on specific clinical pathoanatomical tests to reveal which tissues were 
affected, rather than a less specific diagnosis set by others (Refshauge et al., 1995).
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Much of the early physiotherapy research was performed by medical doctors and 
included aspects of pathological and therapeutic mechanisms on a microscopic or 
organic level, as well as clinical studies. When Physiotherapy entered the research 
arena, more of the published studies were of a clinical nature focusing on global 
treatment effects rather than biological mechanisms of action. 
In the field of EPAs it also became clear that much of the literature on physical 
modalities regarding penetration and absorption of energy in the skin barrier was
sparse and quickly became outdated. Another poorly investigated area for physical 
modalities is related to their time-effect-profile, and consequently the importance of 
tailoring the timing of interventions to the pathophysiological processes at play.
1.1.1 EPAS IN PHYSIOTHERAPY
Since the early days of physiotherapy, EPAs modalities have been part of our
intervention toolbox. An underlying premise of all EPAs interventions is that 
application of energy can alter the living body’s biological processes.  The biophysical 
effects from tissue heating affect the body’s homeostasis and metabolic reactions, and 
induce vasodilatation and specific tissue changes like tendon extensibility and fluids 
viscosity (Lehmann, 1953; Rivenburgh, 1992; Rennie and Michlovitz, 1996; Collins, 1996; Watson, 2000;
Robertson et al., 2006).
In physiotherapy, different interventions are combined to achieve an optimal 
intervention package (Figure 1). EPAs are often used for preparing the tissue for local 
manual techniques or therapeutic exercise. EPA modalities are rarely used alone as 
monotherapies (Watson, 2000; Robertson et al., 2006).
Figure 1. Scope of physiotherapy practice, pillars of treatment
(BMJ, 1929; CSP, 2006)
Massage Exercise and 
movement
Electrophysical 
Agents (EPAs)
Kindred methods 
of treatment
Physiotherapy
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The role of EPAs over recent decades has changed from being preparative modalities
for other interventions, to becoming a more autonomous modality which can modulate 
pain and physiological processes during the inflammatory, proliferation and 
remodelling phase of tissue repair (Robertson et al., 2006; Kitchen and Young, 2008). In this 
perspective EPAs can be interpreted as competitor and substitute for painkiller drugs 
rather than a supplement to exercise and movement therapies.
Technological development has both improved the number of electrophysical 
treatment devices, and increased the assortment of electrophysical examination devices
suitable for use by physiotherapists. At the World Confederation for Physical Therapy 
(WCPT), in Amsterdam 2011, where the International Society for Electrophysical 
Agents in Physical Therapy (ISEAPT) was implemented as an expert subgroup under 
WCPT, electrophysical diagnostic and evaluation methods were included in the 
definition of EPAs in physiotherapy (WCPT- ISEAPT, 2011).
1.2 A BRIEF HISTORICAL VIEW OF RESEARCH ON LIGHT
The theory categorizing light as being of electromagnetic nature was proposed by 
Faraday in the mid-19th century (Tyndall, 1922), and put forward by Maxwell in “A 
Dynamical Theory of the Electromagnetic Field” (Maxwell, 1864). The scientific 
evidence for the analogy of light and electrical wave motion was demonstrated around 
the turn of the 19th to 20th century by Lorentz and Zeeman (The Nobel Organizations, 2012a).
About the same time, Planck deduced the relationship between energy (E) and 
frequency (v) of radiation, E=hv (The Nobel Organizations, 2012b). In the early 20th century 
Millikan made a direct determination of Planck’s constant h, as well as the elementary 
charge of a single electron (Millikan, 1913).
Another important contribution to physics of light came from Einstein. Experiments 
like Hertz’s observations of charged objects losing their charge after light
illuminations could not be explained by the wave theory. Einstein came up with a 
theory of light sometimes behaving as particles - called the photoelectric effect. The
photoelectric effect is a phenomenon where particles are emitted from matter after the 
absorption of energy from electromagnetic radiation (The Nobel Organizations, 2012c).
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During experiments of the scattering process, Compton demonstrated that for each 
scattering electron there are scattering photons (Compton, 1927). The photoelectric effect, 
together with Compton’s scattering effect, have contributed to our understanding of 
the wave-particle duality of light (Ekspong, 1999). During the 20th century there was much
research in physics on elementary particles, and in the 1950s Kastler showed that 
electrons can be put into excited sub-states by polarized light. Based on “amplification 
of stimulated emission of radiation” in the specter of light (laser) Basov/Prokhorov and 
Townes developed the first lasers in the late 1950s (Karlsson, 2000), and  Maiman 
reported in 1960 his creation of the first ruby laser (Maiman, 1960).
The application of lasers range from low power lasers for purposes such as remote 
controllers and pointers, therapeutic devices for normalizing tissue homeostasis and 
reducing pain, to high power lasers for medical surgery and metal cutting devices for 
industrial use.
1.2.1 LOW-LEVEL-LASER-THERAPY (LLLT) LASERS
A laser consists of a lasing media in a resonating cavity, and an energy source. The 
supplied energy “pumps up” the lasing media to stimulate emission of radiation. 
Different types of lasing media have their specific wavelengths of radiation. Lasers are
characterized by emitting monochromatic and coherent light. The monochromatic light 
occurs as it is clustered around a single wavelength. By synchronizing the light’s 
“rhythm” it gets a high degree of coherence.
Lasers used for LLLT are typically of class 3B, classified by an average output power
range between 5-500 mW (IEC, 2007). The unit for irradiated energy per second is W, 
also termed the mean output power (MOP). Commonly used wavelengths in LLLT are 
in the red- and near-LQIUDUHG EDQG Ȝ –1000 nm) (Karu, 2007), where the energy 
absorption in water and cutaneous melanin pigment is low (Anderson and Parrish, 1981).
LLLT lasers can operate in different output modes; continuous or pulsed. Continuous 
mode has a constant output power in the emitted energy, and MOP is equal to pulse 
power output. In pulse mode, MOP is a product of pulse power (W), pulse width (sec) 
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and pulse per second (Hz), as it is an energy average of the total amount of energy in 
pulses per second. There are two types of pulse mode in LLLT: Chopped-pulsed mode
where pulse peak power is <500 mW; and superpulsed mode with high pulse peak 
power far above the 500 mW limit, but of ultra-short duration in the nanoseconds
range (10-9 sec.) and long pauses making the average output of typically less than 100 
mW MOP.
The unit for delivered energy in an irradiated point in LLLT is Joule (J), also called the
energy dose. Another element in LLLT is the laser beam spot size (cm2) or the cross 
section area. The spot size is critical for power density (mW/cm2) calculations but is 
hard to define as the beam power distribution is not homogeneous. In addition to the 
spot size, the probe lens also shapes the laser beam. Commonly used laser probe lenses 
are flat or convex. A flat lens does not change the shape of the beam, while a convex 
lens reduces the natural angle of beam divergence caused by the laser diodes.
1.2.2 LLLT AS THERAPEUTIC INTERVENTION
During the 1960s, experimental research was done with gas lasers in biological tissue
(Goldman et al., 1963; Mester et al., 1968a), and the first papers on the biostimulating effects 
from LLLT irradiation with HeNe gas lasers were published (Carney et al., 1967; Mester et al., 
1968b; Goldman et al., 1968).
Most of the early LLLT research focused on possible stimulation of cell proliferation. 
Various in vitro studies have shown that LLLT can stimulate cell metabolism in HeLa 
cells (Karu et al., 1984), Schwann cells (Van Breugel and Bar, 1993) and fibroblasts (Young et al., 
1989; Loevschall and Arenholt-Bindslev, 1994; Yu et al., 1994). Similar in vivo animal studies with 
experimental injuries of various tissue types like skin (el Sayed and Dyson, 1990), cartilage 
(Nicolopoulos et al., 1996), tendons (Reddy et al., 1998), muscles (Bibikova and Oron, 1993) and
nerves (Rochkind, 1992; Anders et al., 1993) found positive effects from LLLT on the healing 
process. Partly in parallel with this, a few researchers took an interest in investigating 
possible LLLT effects in inflammation, but only scattered studies were performed with 
contradictory results (Young et al., 1989; Honmura et al., 1992; Bouma et al., 1996). During the late 
1990s LLLT interest picked up again, and Japanese dental research groups were 
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particularly active in this period (Shimizu et al., 1995; Ozawa et al., 1997; Sakurai et al., 2000; Takema 
et al., 2000; Nomura et al., 2001).
Publication activity for LLLT research was picking up around the turn of the 21st
century. LLLT was demonstrated to act biomodulatory through light absorption of 
photoreceptors (Karu, 1999). These photoreceptors absorb light leading to a cascade of 
metabolic reactions in cells (Karu, 2008). It has been demonstrated that cytochrome c 
oxidase (the terminal enzyme in the electron transport chain) is the photoreceptor and 
that the initial reactions result in changes in the presence of nitric oxide (NO), reactive 
oxygen species (ROS) and adenosine triphosphate (Karu et al., 2004; Karu et al., 2005; Karu et 
al., 2008). Recently, the anti-inflammatory effects from LLLT have been extensively 
investigated and several aspects of the inflammatory process can be modulated by 
LLLT. In studies investigating the gene expression profiles of human fibroblasts, most 
genes enhance cell proliferation and/or suppress apoptosis, directly or indirectly, from 
LLLT (Yu et al., 1994; Zhang et al., 2003; Frigo et al., 2010; Chen et al., 2011). LLLT also reduces
expression of pro-inflammatory mediators (Rizzi et al., 2006; Pires et al., 2011) and regulate
oxidative stress (Fillipin et al., 2005; Rizzi et al., 2006; Moriyama et al., 2009).
An increasing amount of fairly homogeneous results from in vivo studies strengthened 
the support for a positive anti-inflammatory response from LLLT in injured tendons
(Salate et al., 2005; Elwakil, 2006; Oliveira et al., 2009; Pires et al., 2011; Marcos et al., 2011; Marcos et al., 
2012), -muscles (Rizzi et al., 2006; Mesquita-Ferrari et al., 2011; de Souza et al., 2011), -joints (Moriyama 
et al., 2005; Moriyama et al., 2009; Pallotta et al., 2012) and in soft tissue (Albertini et al., 2004).
A pain reducing effect from LLLT has been demonstrated in clinical studies on human 
tendinopathies (Stergioulas, 2003; Bjordal et al., 2006b; Stergioulas, 2007; Stergioulas et al., 2008), neck 
pain (Gur et al., 2004; Chow et al., 2006; Chow et al., 2009; Konstantinovic et al., 2010), myalgia (Gur et 
al., 2002; Chow et al., 2009), low back pain (Jovicic et al., 2012) and knee osteoarthritis (Gur et al., 
2003; Hegedus et al., 2009). The mechanisms behind pain relief are not fully understood. A 
possible explanation is a nerve blocking effect from LLLT that was demonstrated by 
Chow et al. (2007) in laboratory study. Also, suggestions of pro-inflammatory cytokines 
as a trigger for pain (Brenn et al., 2007; Kawasaki et al., 2008), makes the anti-inflammatory
effects a possible explanation for pain relief. 
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1.3 THE SKIN
The skin is the largest organ of the body, and its` outer boundary for protection. The 
skin is the first line of defense against intrusions and infections but also a barrier for 
energy applied from EPAs used in physiotherapeutic treatment. Mammalian skin 
consists of epidermis and dermis. The thickness of both skin layers varies with 
anatomical location in the body. 
Human epidermis thickness varies from 0.04 mm to 0.4 mm, and is thinnest on the 
trunk and thickest in the palm of the hand and under the sole of the foot  (Millington and 
Wilkinson, 2009). About 5-10% of cells in epidermis are melanocytes (Holbrook et al., 1988).
The type and amount of melanin in the epidermis determine our skin colour (Alaluf et al., 
2002; Yamaguchi et al., 2007), and play a central role in photo-protection of the skin 
(Giacomoni, 1995; Taylor, 2002). Dermis thickness ranges from 1 mm to 4 mm (Igarashi et al., 
2005). Dermis is rich in blood vessels and sensory nerve endings, these are inter alia
involved in thermoregulation (Ovalle and Nahirney, 2008). Hemoglobin also has light 
absorption bands in the red- and near-infrared radiation spectrum (Mobley and Vo-Dinh, 
2003). The skin is attached to underlying structures by hypodermis, a subcutaneous 
fatty layer. The hypodermis also contains blood vessels and nerves (Kanitakis, 2002; Guyton 
and Hall, 2006).
Human skin appearance, structure, and biophysical properties differ with body location 
and between individuals according to their race, age and sex (Taylor, 2002; Costin and 
Hearing, 2007; Millington and Wilkinson, 2009). The skin ageing process leads to loss of 
collagen and elastin fibers; reductions in the size of epidermal, dermal and 
subcutaneous layers contribute to fragility, loss of laxity and a dry fine wrinkled 
appearance of the skin (Montagna and Carlisle, 1979; Leveque et al., 1984; Yaar et al., 2002; Farage et 
al., 2007). Genetic disposition and hormones also have an influence on the skin structure. 
After the menopause, female skin thickness decreases due to lower levels of estrogen 
(Shuster et al., 1975; Zouboulis et al., 2007).
Rat epidermis thickness varies from 0.01 mm to 0.07 mm, and dermis thickness ranges
from 0.5 mm to 2.2 mm (Bronaugh et al., 1983; Regan Thomas, 2005), which is not unlike the
human skin in miniature.
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1.3.1 OPTICAL PROPERTIES OF SKIN
LLLT is the application of light typically of wavelengths in the red and near infrared 
range (Ȝ 600–1000 nm). Radiated energy may be reflected off the skin surface, 
absorbed within-, or penetrate through the skin. The reflected part of incident radiation 
of red and near-infrared wavelengths with a beam angle of 90 degrees to the human 
skin is small, ranging between 4% and 7% (Anderson and Parrish, 1981). Radiation 
penetrating the outer skin layer is partly absorbed by melanin in the epidermis and 
hemoglobin in the dermis (Kollias, 1995; Prahl, 1999; Jacques, 2001). Energy absorption by 
melanin in the skin decreases with longer wavelengths in the interval of Ȝ 600-1000
nm (Anderson and Parrish, 1981; Mobley and Vo-Dinh, 2003; Bashkatov et al., 2005; Bashkatov et al., 2011;
Nedosekin et al., 2012). Absorption by hemoglobin also decreases towards longer 
wavelengths with negligible absorption at wavelengths above Ȝ 650 nm (Prahl, 1999;
Roggan et al., 1999; Barun and Ivanov, 2003; Bashkatov et al., 2005; Bashkatov et al., 2011).
Within the skin, part of the radiated energy is refracted and scattered in random 
directions. This scattering contributes to extending the distribution of energy beyond 
the collimated beam. Scattering is strongest from wavelengths under Ȝ 500 nm and 
decreases with longer wavelengths (Kollias, 1995; Bashkatov et al., 2005; Bashkatov et al., 2011).
During LLLT irradiation the probe is usually held in skin contact. With the laser probe 
in skin contact, reflected energy, in addition to the probe’s diode and electronics, will 
heat the tip of the probe. This again will affect temperature in the surrounding skin. 
Therefore, measuring the thermal effect on human skin is an indirect way to 
investigate whether the energy from LLLT is absorbed by, or if it penetrates through,
the skin.
1.3.2 LLLT’S SKIN PENETRATION ABILITIES
In order to interact with deeper tissue the radiated energy from LLLT has to penetrate 
through the skin barrier. Two decades ago, it was stated that most of the energy from 
Ȝ .8 nm and 820 nm lasers was absorbed within the first 0.4–0.5 mm in human 
skin (Kolari and Airaksinen, 1993). But more recent studies have shown that the energy from 
Ȝ 850 nm laser was only reduced by 66% after being transmitted through  human skin 
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flaps of 0.784 mm thickness (Esnouf et al., 2007). Another study in female breast skin flaps 
demonstrated that RIWKHHQHUJ\IURPȜ 694 nm lasers actually penetrates at least 
1 mm downward through the human skin (Topping et al., 2001).
Biophysically, the ability of radiated energy to penetrate tissue is dependent on the 
laser’s wavelength. Light in the interval of infrared wavelengths (Ȝ 750-1000 nm)
penetrates tissue better than light in the interval of red wavelengths (Ȝ 600-750 nm)
(Anderson and Parrish, 1981; Stolik et al., 2000). Bashkatov et al. (2005) calculated optical 
penetration depth į OLJKW DWWHQXDWLRQ WR  to be 1.5 mm from red wavelengths 
(Ȝ 600 nm) and 3.5 mm from infrared wavelengths (Ȝ 1040 nm). In clinical studies
laser irradiation in skin flaps has shown an almost linear increase in penetration with 
wavelengths from Ȝ 450 nm to 1030 nm (Ackermann et al., 2002). A similar wavelength 
dependent penetration depth was also found in a clinical study where a wavelength
Ȝ 675 nm penetrated slightly better than a wavelength of Ȝ 632.8 nm in human skin 
flaps (Kolarova et al., 1999). Other studies have reported similar findings with wavelength-
dependent penetration in animal skin (Beek et al., 1997; Enwemeka, 2001).
1.4 TENDONS
Tendons transmit tensile load from muscles to bone. They consist of an extracellular
matrix (ECM) and cells. Even though composites vary from tendon to tendon, the ratio 
of cells to ECM is approximately 1:4 (Kannus, 2000; Nordin and Frankel, 2001; Kjaer, 2004). Cells 
have the essential function of maintaining ECM by synthesizing and degradation of its 
substances. Fibroblasts cells are the main cell type in tendons. The solid substance in 
ECM is mainly collagen type-I mixed with proteoglycans that acts as a binder 
stabilizing the collagen structure. This morphological structure gives tendons the 
unique mechanical ability to tolerate high unidirectional tensile load (Jozsa and Kannus, 
1997; Riley et al., 1994; Kjaer, 2004; Rumian et al., 2007).
Literature on tendons often state that tendons have relative limited vascularization and 
low metabolic rate (Jozsa and Kannus, 1997; Kannus, 2000; Cook et al., 2002; Kjaer, 2004; Theobald et 
al., 2005; Sharma and Maffulli, 2006), which is projected from less blood vessels in tendinous 
tissue (Lang, 1960; Lang, 1963) compared to muscles (Jozsa and Kannus, 1997; Kjaer, 2004).
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However, some studies have demonstrate that collagen synthesis (13C- and 15N-prolin
protein fraction synthetic rate per hour) is higher in human tendons than in muscles 
(Babraj et al., 2005), and that it has an acute increase following exercise (Miller et al., 2005). It 
has also been demonstrated that vascularization in peritendinous tissue increases
significantly following exercise (Langberg et al., 1998; Boushel et al., 2000), which indirectly 
can interpret an increased intratendinous blood flow.
As aging progresses, tendon metabolic rate and mechanical properties as tensile 
strength and stiffness decrease (Kannus, 2000; Nordin and Frankel, 2001).
There are relatively few nerves inside tendons. Nevertheless both the myotendinous 
and the osseotendinous junction are well innervated, but in long tendons the mid-
portion section are usually poorly innervated (Andres et al., 1985; Jozsa and Kannus, 1997).
The morphological structure and chemical composition of tendons are identical in 
humans and other mammals (Amiel et al., 1984; Nordin and Frankel, 2001).
1.4.1 TENDINOPATHY 
The term tendinopathy describes all types of non-rupture tendon disorders. Human 
tendinopathy is probably a result of multiple factors and with potentially differing 
aetiology. Research on the aetiology of tendinopathy is complex, and even though 
tendinopathies have been exhaustively studied through the last decades, the exact 
etiologic initiation of tendon pain remains unclear (Jozsa et al., 1990; Almekinders and Temple, 
1998; Maffulli et al., 2003; Wang et al., 2006; Cook and Khan, 2007).
The origin of human tendinopathy is commonly designated to overuse injuries (Khan and 
Maffulli, 1998; Almekinders and Temple, 1998; Cook et al., 2002; Maganaris et al., 2004). Overuse is 
suggested to be critical for development of tendon pain, but mechanical overload is not 
the sole reason for tendon pathology (Almekinders and Temple, 1998; Cook and Khan, 2007).
Human tendinopathy also occur following external trauma to tendons (Wedderkopp et al., 
1997; Agel et al., 2007; Garau et al., 2008).
Acute tissue injuries induce a complex cascade of actions in the immune system,
including activation of integrin’s and cytokines (Kindt et al., 2007). The inflammatory 
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processes are within days gradually undertaken by tissue repair, and during the next 
weeks to months tissue remodeling processes will reestablish the basal synthesis
/degradation homeosthasis (Koob, 2002; Lin et al., 2004; Sharma and Maffulli, 2006).
Human tendinopathies are often irresponsive to treatment and around one in five 
patients develop chronic symptoms (Jarvinen et al., 1997; Almekinders, 1998; Cook et al., 2002). It
has been suggested that chronic tendinopathy is a consequence of a failed healing 
response in the immune system (Sharma and Maffulli, 2005a; Longo et al., 2009).
The pathology in tendinopathies, either caused by overuse or trauma, results in an 
inflammatory response with extravasation and tendon swelling (Kindt et al., 2007).
Swelling can occur as both intratendinous and peritendinous edema. These 
pathoanatomic changes seen in tendinopathies can be traced during the tendon’s 
inflammatory- to remodeling phase, and our experience is that increased tendon 
thickness in humans can be observed long after the tissue becomes pain-free.
1.4.1.1 ANIMAL MODELS IN TENDINOPATHY RESEARCH
Human tendinopathies are multifactorial, and research in human tendinopathies is 
complex with ethical limitations in inflicting and evaluation methods. Use of animal 
models in tendinopathy research has the advantage of incorporating invasive 
evaluation techniques, detailed tissue examination and analysis of biochemical 
substances. Animal models may be useful in reproducing some aspects of human 
tendinopathy by providing researchers with the power to control variability (Warden, 
2007; Lui et al., 2011).
In the literature, animal models of tendinopathies can be grouped in two categories: 
Models where tendinopathy is induced by chemical agents; and models which induce 
tendinopathy through mechanical load or injury (Lake et al., 2008). The latter is commonly 
done by excessive repetitive loading and can be appropriate in investigating
tendinopathy related to overuse (Carpenter et al., 1998; Soslowsky et al., 2002). Increased levels 
of inflammatory mediators have been found in animal tendons after excessive activity 
(Perry et al., 2005). These findings fall in line with studies on healthy human tendons 
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exposed to excessive activity (Langberg et al., 1999; Langberg et al., 2002; Boesen et al., 2006).
Another model for mechanical load is inflicting a blunt tendon trauma transversely
over the tendon fibre direction. Experimentally, this can be done by a mini-guillotine 
where a blunt metal blade inflicts a crush trauma to the tendon. Studies on rat Achilles 
trauma by such a mini-guillotine reveal significant histological changes compared to 
healthy tendons. The injured tendons yield a significant difference in collagen fibre 
alignment (Oliveira et al., 2009) and  increased number of vessels (Salate et al., 2005) 3 days 
after the injury. Another study has found moderate inflammation in injured tendons 24 
hours, 7, 14 and 21 days after trauma with this model (Fillipin et al., 2005).
1.4.2 LLLT IN TENDON TREATMENT 
LLLT has been used in lots of clinical studies on human tendons. In a review of LLLT 
administered for lateral elbow tendinopathies (within the WALT therapeutic 
windows), LLLT seemed to offer pain relief and reduced disability (Bjordal et al., 2008). In
an intervention study on Achilles tendinopathies, pain relief experienced by patients 
was significantly better after 4, 8 and 12 weeks of eccentric exercise and LLLT 
compared to eccentric exercise and placebo LLLT (Stergioulas et al., 2008). In another 
study, it was demonstrated that LLLT modulates inflammation by reducing PGE2 in 
activated Achilles tendinopathy in human (Bjordal et al., 2006b).
In laboratory studies, LLLT has been performed on a variety of different pathological 
conditions, including injured animal tendons. Histopathological improvement in the 
LLLT treated groups has been observed in terms of increased collagen production 
(Reddy et al., 1998), improved collagen bundles organization (Carrinho et al., 2006; Elwakil, 2006;
Arruda et al., 2007; Oliveira et al., 2009),  and increased number of small blood vessels (Salate et 
al., 2005). In most of these laboratory studies the effect from LLLT has been evaluated 
after 3 to 21 days of treatment.
Lesser research focus has been given to the spontaneous effect from LLLT within 24 
hours after injury and acute tendon inflammation. However, after induction of 
inflammation followed by 3-4 LLLT sessions, tendons have exhibited lower
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concentrations of inflammatory markers in the LLLT-treated groups when compared 
to no treatment controls 24 hours after injection (Aimbire et al., 2006; Correa et al., 2007).
1.5 MEASURING METHODS
In the 1990s a shift in interpretation of research results was seen with the evolution of 
evidence-based practice. Seeking the best available evidence from quality-assessed 
research findings in clinical trials became popular among health professionals (Bury, 
1998; Herbert et al., 2005). Scientific evidence was incorporated into all aspects of 
physiotherapy practice, including examination, intervention and evaluation. The
evidence for good measuring methods was obtained through studies of their validity, 
reliability, and ability to discriminate, predict and show sensitivity to change. The 
evidence for appropriate interventions includes proof of some biological action from 
the active ingredients and a positive clinical response to the intervention.
The interface of irradiating energy and biological tissue is an aspect which requires 
reliable methods to measure the effects from LLLT. Two obviously measureable 
biophysical effects from LLLT are; 1) how much of the irradiated energy can be traced
in the skin surface, and 2) how much of the irradiated energy penetrates through the 
skin. The biophysical measure of increased temperature reflects energy absorption and 
transformation in the skin during LLLT irradiation. This thermal effect can be 
measured in the skin surface by thermography. The other biophysical effect from 
LLLT irradiation can be measured by an optical power meter as the fraction of optical
energy that penetrates through the skin.
The biological effects from LLLT irradiation in tissue are usually measured at the
microscopic level as histological evaluation (Reddy et al., 1998; Salate et al., 2005; Fillipin et al., 
2005; Elwakil, 2006; Carrinho et al., 2006; Arruda et al., 2007; Oliveira et al., 2009). In a couple of
studies the biological effects have been evaluated at the macroscopic level as tissue 
mechanical properties (Elwakil, 2006; Ng and Fung, 2008). Another measuring method of 
tissue on the macroscopic level is RTUS. RTUS measurements are rarely used in small 
rodents, but RTUS is commonly used to detect pathology in human tissue.
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1.5.1 THERMOGRAPHY
Thermography is an imaging method, which measures thermal energy emitted from an 
object. Thermographic cameras convert invisible infrared radiation to electronic 
signals, which is then processed to temperature calculations and visible colour images. 
Traditionally, human skin temperature is measured by in-contact sensors like the 
mercury thermometer and the electronic thermometer. Human skin temperature 
measured by thermography has small inter-subject variability in repeated 
measurements (Roy et al., 2006; Howell et al., 2009). Body temperature measured on 
thermographic images has high reliability compared to rectal temperature measured  
with mercury thermometer (De Curtis et al., 2008). Thermography also yields high 
sensitivity in diagnosing morphoea (Martini et al., 2002) and in detecting Raynaud’s 
syndrome (Gold et al., 2004).
An advantage of thermographic camera is that it works as a non-contact device with 
little risk of contact-induced infections. 
1.5.2 OPTICAL POWER METER
An optical power meter consists of a sensor measuring energy in an optical signal, and 
is connected to a console and display unit. The sensors are photodiodes, which are 
sensitive to specific ranges of wavelengths and power levels. 
An optical power meter can be tuned to certain laser wavelengths, where it can 
measure the mean optical output (MOP) in the optical signal.
1.5.3 REAL TIME ULTRASONOGRAPHY (RTUS)
The piezoelectric crystal in ultrasound transducers converts electrical impulses to 
sound waves and vice versa. In ultrasonography, sound waves are transmitted into the 
body where they are reflected differently depending on the type of tissue. The reflected 
sound waves are collected by a receiver and processed through software to create
sonoanatomic images. Tissue of high density (impedance) is displayed in bright grey-
shades, and tissue of low density is displayed in dark grey-shades. This grey-scale 
imaging is called B-mode (brightness mode), and is commonly used in several areas of 
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medicine. Ultrasonography, for medical purpose, operates with frequencies from 1 
MHz to 20 MHz (Siemens, 2010; GE, 2011). The transducer frequency is important for the 
image resolution: Higher frequencies give higher resolutions image, but have lower 
tissue penetration depth; and vice versa for lower frequencies. High frequency 
transducers (10-20 MHz) offer high resolution and are most appropriate for 
musculoskeletal imaging. Other features emphasizing ultrasonographic images are 
Coded Harmonics and CrossXBeam: Coded Harmonics enhances the details in images
by brighter and more continuous boundaries, and CrossXBeam is a coplanar imaging 
technic to reduce noise in images (Cruz-Colon et al., 2006).
Ultrasonography is also a real-time imaging method (RTUS). Technical improvement 
in RTUS the last decades has made this imaging method valuable in the examination 
of musculoskeletal disorders, and RTUS has become popular among physiotherapists 
who seek diagnostic identification of tendinopathies. RTUS has high reliability and 
good sensitivity in detecting tendon abnormalities (Koski et al., 2006; Sein et al., 2007; Bashford 
et al., 2008), and RTUS has high accuracy compared to magnetic resonance imaging
(MRI)  (Khan et al., 2003; Kamel et al., 2004; Warden et al., 2007) and surgical findings (Hartgerink et 
al., 2001; Prickett et al., 2003). An advantage of RTUS compared to MRI and computed 
tomography (CT) is the opportunity of examination of tissues real-time during 
movements.
1.5.4 ULTIMATE TENSILE STRENGTH (UTS)
Tensile testing is performed as mechanical tests of tissue in material-test-machines,
where a controlled load moves at a fixed speed pulling on the specimen. Ultimate 
tensile strength (UTS) is the maximum load and elongation that a specimen can 
withstand before the breaking point. 
The biomechanical properties of tendons have been tested to determine their UTS. In 
two animal studies, healthy rat Achilles tendons were dissected and stretched to UTS-
values of 42.5 N (SD ±5.5) (Kilkelly et al., 1996) and 48 N (SD ±11.0) (Wieloch et al., 2004).
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An important and yet unanswered question in tendon research is whether the
appearance of tendinopathies affects tendons tensile strength during different phases 
and severity grades of the disease.
1.6 THE RESEARCH QUESTION
LLLT interventions are commonly used to interact with pathological tissue beneath the 
skin. However the massive photo-protective property of the skin is a significant barrier 
which has to be considered to achieve optimal application of LLLT.
The irradiated energy first interacts with the skin, where some of the energy is 
reflected and some is absorbed. This gives rise to biophysical energy transformation 
processes and heat production in the skin. The remaining energy from the irradiation 
will penetrate through the skin, where it can be an active ingredient in ongoing 
photobiological processes in deeper tissue.
The research question in this Thesis is: What are the biophysical and biological effects 
from commercial infrared LLLT lasers commonly used in clinical physiotherapy 
practice?
The scope of the Thesis is to reveal some of the biophysical effects in skin during 
LLLT irradiation, and biological effects from LLLT in acute tendon trauma (Figure 1,
p.28). In this perspective studies were designed to investigate if biophysical 
differences occur between the two most common types of commercially available 
LLLT lasers (infrared class 3B) where specifications for wavelength, irradiation mode 
and MOP differ. Secondly, the thesis will investigate two possible biological 
macroscopic effects from one of these infrared LLLT laser on a traumatized tendon.
1.6.1 THE OBJECTIVE FOR STUDY I
In LLLT irradiation some of the optical energy is converted to heat, when it is 
absorbed in biological tissue. During application of LLLT, the probe is usually held in
a fixed position in skin contact. The reflected energy from the skin, in addition to 
energy from the diode and electronics in the probe, will heat the probe tip. An 
increased temperature in the laser probe tip will heat the skin by convection. In this 
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way both absorbed and reflected energy from LLLT irradiation contribute to 
conversion of radiant energy to thermal energy.
There is a lack of research on whether the thermal effects are at play in treatment with
commonly used infrared class 3B lasers. A search with the terms ‘‘thermal effects’’,
‘‘human skin,’’ and ‘‘laser’’ in PubMed, Embase, Cinahl, ISI Web of Science and 
ScienceDirect (October 2009) yielded no clinical studies performed with class 3B 
lasers.
The objective of study I is to investigate the biophysical effect from LLLT lasers as 
heat in human skin.
1.6.2 THE OBJECTIVE FOR STUDY II
The few existing clinical LLLT studies that deal with penetration issues, have largely 
focused either on optical energy loss (Topping et al., 2001; Esnouf et al., 2007) or penetration 
depth (Kolarova et al., 1999; Enwemeka, 2001). LLLT intervention is typically administered 
during irradiation periods lasting from 10-20 sec up to a few minutes, but no studies 
have yet investigated the time-profiles for skin penetration of optical energy from 
infrared class 3B lasers.
The objective to study II is to determine the biophysical time-profiles for optical 
energy penetrating skin from LLLT lasers.
1.6.3 THE OBJECTIVE FOR STUDY III
A rat Achilles tendon trauma inflicted in a mini-guillotine model cause histological 
abnormalities 3 days after an injury (Salate et al., 2005; Oliveira et al., 2009), but it is not 
known whether these morphological changes affect biological outcomes such as UTS
values, tendon structure or edema. 
The objective to study III is to investigate whether a LLLT irradiation within half an 
hour after a tendon trauma cause biological effects in tendon thickness and tendon’s 
UTS.
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Figure 1.  Internal relationship between studies in the Thesis. 
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2.  AIM OF THE THESIS 
The overall aim of this Thesis is to investigate biophysical and biological effects from 
commonly used LLLT laser devices where specifications for wavelength, irradiation 
mode and MOP differ.
The aims of the three studies in the Thesis are:
Study I to investigate the biophysical effects of two therapeutic LLLT lasers on skin 
temperature in healthy participants of different skin colours, age and genders.
H0: There are thermal effects in human skin of high doses from infrared LLLT 
class 3B lasers, varying with irradiated dose and participants’ skin colour, 
age and gender.
H1: There are no thermal effects from infrared LLLT class 3B lasers in human 
skin, regardless of irradiated dose and participants’ skin colour, age and 
gender.
Study II to investigate the biophysical rat skin penetration ability of two therapeutic 
LLLT lasers during 150 seconds of exposure.
H0: A fraction of the optical energy from infrared LLLT class 3B lasers 
penetrates through rat skin during commonly used LLLT irradiation times.
H1: Optical energy from infrared LLLT class 3B lasers does not penetrate 
through rat skin during commonly used LLLT irradiation times.
Study III to investigate the biological effects of LLLT on tendon and peritendinous 
edema measured by RTUS and UTS when LLLT is administered half an 
hour after inflicting an Achilles tendon trauma. 
H0: A single LLLT dose, after an acute tendon trauma, has biological effects on 
the injured tissue.
H1: There is no effect from a single LLLT dose after an acute tendon trauma.
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3. METHODS
3.1 DESIGNS
Experimental research is characterized by controlled manipulation of variables by the 
researcher. Controlled manipulation enables researchers to draw causal conclusions 
about the variable under study. Single-factor experiments are trials where the 
researcher manipulates only one variable. The single-factor experiment of repeated 
measures design means that the same subjects are measured under all the levels of the 
independent variable. The single-factor experiment of post-test-only control-group 
design, means that post-test is the only basis on which judgements are made about the 
effect of the independent variable on the dependent variable (Domholdt, 2005).
The investigation of effects from LLLT lasers in biological tissue is best explored in
clinical and laboratory single-factor experimental studies. This project includes three 
trials with these research designs.
STUDY I – is a blinded placebo-controlled study on LLLT in in situ human skin. The 
study has a repeated measures design.
STUDY II – is a basic research study on LLLT in in vivo rat skin. The study has a 
repeated measures design. 
STUDY III - is a double blinded randomized controlled trial on LLLT in in situ/in vivo
rat Achilles tendons. The study has a post-test-only control-group design.
3.2 ETHICS
The protocol for study I was approved by the Regional Committee for Medical and 
Health Research Ethics (Appl.no: 091.08), and informed consent was obtained from all 
participants. 
The protocol for study II and study III was approved by the Norwegian Animal 
Research Authority (Appl.no: 20102676).
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3.3 SUBJECTS
STUDY I
This study includes healthy volunteers stratified for skin colour, age and gender.
Participants were recruited from the staff at Bergen University College, Bergen 
University and local immigrant associations. The sample consists of 40 persons of
both genders, three age groups (<40, 40-60, and >60 years of age), and three skin 
colour groups (light, medium, and dark skin), (Paper I, Table 1). Individuals with a 
history of skin disease were excluded. 
STUDY II AND STUDY III
These studies were done with Spangue Dawley male rats, weight 250-300 g. Rats were 
housed four and four in individually ventilated cages under a light cycle of 12+/12-.
The humidity was of 55%. The temperature ranged from 20 to 22°C, and the rats 
received water and food ad libitum.
STUDY II - This study includes 62 harvested skin flaps overlaying the rat 
gastrocnemius muscle.
STUDY III - This study includes 32 Achilles tendons from 16 animals. Animals were 
divided in two groups of 8 animals (active-LLLT/placebo-LLLT), and housing cages 
were labeled with group identification.
3.4 INSTRUMENTS
STUDY I
Skin temperature was measured by a thermographic camera (Flir System, 
ThermaCAM S65HS) and ancillary software (ThermaCAM Researcher Pro 2.8 SR-1). 
This software includes tools for quantifying the recorded temperature. The camera 
measures temperatures with a precision of 50 mK at 30°C and has an accuracy of ±2%
(Manufacturer´s specification).
Two commercial infrared class 3B lasers were used for irradiation as follows:
i) 810 nm wavelength laser (Thor-DD, UK), operated in continuous mode with 
200 mW MOP, spot size 0.0314 cm2 (Manufacturer’s specification); 
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ii) 904 nm wavelength laser (Irradia, Sweden) operated in superpulsed mode: 
Peak power 20 W, pulse train frequency 6 kHz and pulses 100 nsec (10-9 sec)
width (=30.000 pulses per sec), 60 mW MOP, and spot size 0.0364 cm2
(Manufacturer’s specification).
(In Paper I: 60 mW MOP is correct, but pulse specifications are not correct).
STUDY II
The energy penetrating through rat skin was measured with an Optical Power Meter 
system (Thorlabs Instruments, NJ, USA). The Optical Power Meter system consists of 
a PM100 display unit with sample rate 6 Hz and an accuracy ±1%, and a S121B 
Silicon sensor. The S121B sensor input had an aperture with diameter of O=9.5 mm 
with an optical power range 500 nW–500 mW at operating temperature 5°- 40°C, and 
accuracy ±5% (Manufacturer´s specification).
Two commercial infrared class 3B lasers were used for laser irradiation, (the same 
lasers as described in study I above).
STUDY III
A laser, 904 nm wavelength (Irradia, Sweden), superpulsed mode: Peak power 20 W, 
pulse train frequency 6 kHz and pulses 100 nsec (10-9 sec) width (=30.000 pulses per 
sec), 60 mW MOP, and spot size 0.38 cm2 (Manufacturer’s specification), with two 
identical single diode laser probes were used: One with an active laser, and the other 
an inactive/placebo laser source. Probes were labeled.
(In Paper III: 60 mW MOP is correct, but pulse specifications are not correct).
A servohydraulic testing machine (Material Test System MTS-810, Minnesota, USA) 
equipped with a calibrated load cell of 500 N and a position transducer of 100 mm, 
was tuned to a deformation rate of 0.25 mm/sec.
RTUS Logiq-e (GE Healthcare, Minneapolis, USA), operating in B-mode with 
CrossXBeam resolution and Coded Harmonic imaging, and a 15” display screen. 
Imaging depth was 2 cm, with three focus areas around the first cm (Paper III, Figure 
3). The transducer was a linear array with a frequency of 12 MHz. 
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The distal tendon grip was set ad modum Forslund, where the angle between calcaneus 
and Achilles correspond to 30° dorsiflexion of the foot during the UTS test (Forslund and 
Aspenberg, 2001; Dimmen et al., 2009). The proximal end of the tendon was powdered with 
250 m aluminiumoxid (AlOO3). The proximal tendon grip obtained optimal 
mortising with a combination of grip and rolling the tendon around the grip.
3.5 PROCEDURES
STUDY I
During pilot work we observed the temperature in both hands on subjects when 
irradiating one point in one of the hands. The thermography showed heat production 
strictly located to the irradiated point, and temperature in the irradiated area returned to 
baseline skin temperature within 1-2 minutes after irradiation. On the basis of this 
restricted heat localization we decided to use a control area close to the irradiated 
point. By this we wanted to eliminate effect from systemic temperature regulation 
mechanisms. 
Recommended irradiation doses were selected according to WALT guidelines which 
are 2 J for 904 nm lasers and up to 6 J for 810 nm lasers (WALT, 2010). With the thermal 
effects from LLLT irradiation as phenomenon of interest, it was decided also to 
include doses somewhat above WALT’s recommendations. For this purpose, the study 
was designed with doses from 2 J up to 12 J for both devices.
Laser irradiation was performed at the dorsal side of the proximal phalanx of the index 
finger. A neighboring area ulnar to the irradiated area in the proximal phalanx of the 
same index finger was used as a control area (Paper I, Figure 2). The dorsal side of the 
index finger was chosen as this is a relevant area for LLLT treatment of finger 
extensor tendons and inter-phalangeal joints. 
The laboratory air-conditioning where thermal effects were measured was set to a 
fixed temperature of 21°C, and this was monitored during the study. This showed a 
stable temperature throughout the experiment with a room temperature of 21.2°C 
(±0.2°C). 
34 
 
In order to acclimatize the skin temperature, participants dwelled in the laboratory for 
15 minutes before the experiment started. During the experiment participants sat with 
their hands on a towel placed on a table (Paper I, Figure 1). The distance between the 
table and the camera was 25 cm. Participants were instructed that during laser 
irradiation they should report to the investigator if 1)  they felt any heat sensation in 
the irradiated area, and if 2) the heat sensation became so uncomfortable that they 
wanted the laser irradiation to be stopped.
One investigator operated the thermographic camera, and another investigator 
administered laser irradiation. Each session lasted 55 minutes per participant with a 
total of 13 measurements of skin temperature taken. The first measurement was taken 
before any irradiation (i.e. baseline). This was followed by six measurements during 
increasing doses of irradiation from the 904 nm laser, followed by six measurements 
during increasing doses of irradiation from the 810 nm laser. The sequence of the 
doses was the same for both lasers, and as follows: 2 J, placebo (of same duration time 
as 2 J), 6 J, 9 J, 12 J and placebo (of same duration time as 12 J). The 810 nm, 200 
mW MOP laser deliver 1 J in 5 sec, and the 904 nm 60 mW MOP laser deliver 1 J in 
162/3 sec. Placebo irradiation was delivered using the same laser probe as the active 
interventions, but the laser was not switched on. Participants were kept unaware of this 
fact. 
During irradiation the laser probe was held stationary in contact with a fixed spot on 
the skin, and kept in a position approximately 10 degrees from a vertical angle. 
Between each laser irradiation there was a 3 minute break. Thermographic imaging 
was used to ensure baseline skin temperature between irradiated doses.
Thermography was recorded during the last 5 sec of each irradiation dose and 
continued for 1 minute after the end of irradiation (i.e., a total of 1 minute and 5 sec 
per measurement time-point). The maximum temperatures from the irradiated area and 
a control area were registered simultaneously by the ThermaCAM (Paper I, Figure 2), 
and the differences in skin temperature between these two areas constitute the base of 
the thermal effects.
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STUDY II
The protocol concerning animal handling is described in detail in the next section –
Study III.
LLLT devices typically take from between ten seconds and a couple of minutes to 
deliver an irradiation dose. Hence, this study was designed with exposure duration of 
150 sec. 
The Optical Power Meter (PM100/S121B) has five different wavelength options, and 
it was tuned to the same wavelengths as the respective test-lasers Ȝ  nm and 
Ȝ QP. Laser’s MOP was registered at seven time points; immediately after being
activated, after 10 sec, 30 sec and then for every 30 sec until 150 sec (Figure 2).
Data were collected in four steps:
Step one – was a measurement of the two lasers MOP directly into the Optical Power 
Meter. That is with no obstacles between the laser source and the sensor of the Optical 
Power Meter.
Step two – was a measurement of the two lasers MOP after penetrating a plastic film.
That is with a transparent plastic film between the laser source and the sensor of the
Optical Power Meter.
Step three – was a measurement of the two lasers MOP after penetrating through a 
freshly harvested rat skin flap, plus a plastic film. The laser probe was held in skin 
contact. (The irradiated area on the skin flaps had location corresponding to ~2 cm 
proximal from the plantar side of calcaneus on the animal).
Step three started with measurement of the immediate laser MOP directly into the 
Optical Power Meter, and then through a plastic film. After that the skin flap was
placed on the plastic film and the sequence of measuring irradiated MOP through skin 
plus plastic film was performed. This was done for every skin flap and each laser.
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Step four – (same procedure as in step three – but the probe was not held in skin 
contact), the laser probe was now kept approximately 1 mm from the skin surface
during the irradiation.
STUDY III
Experimental setup for tendon strength testing - Pilot testing – The deformation rate 
was discussed with the researchers who carried out a previous study on rat Achilles 
UTS (Dimmen et al., 2009). Based on this and the experience in testing biological tissue at 
the current test-laboratory we decided to use a deformation rate of 0.25 mm/sec. The 
distal grip ad modum Forslund (Forslund et al., 2003) was capable of maintaining a stable 
grip during UTS testing, but the proximal grip was a challenge. The proximal grip, as 
described in literature with use of superglue (Chan et al., 2007) and sandpaper (Demir et al., 
2004), were not sufficient to avoid the tendon sliding in the grip. Nor did railing the grip 
surface and rolling the tendon around the grip prevent the tendon from sliding out of 
the grip. We finally managed to prevent the tendon from sliding by using a 
combination of swabbing the tendon with alumina powder and rolling it around the 
grip. With this setup, tendons now ruptured in the mid-portion, a few millimeters from 
the distal grip. 
Simultaneously, the model for inflicting tendon trauma in a mini-guillotine was tested. 
A trauma was inflicted to the animals’ right Achilles tendon. We started with a single 
trauma, ad modum Lech (Fillipin et al., 2005; Salate et al., 2005; Oliveira et al., 2009), but did not 
achieve pronounced alterations of UTS on the next day between injured (right) and 
healthy (left) tendons. We then decided to repeat the trauma on two consecutive days, 
and now the UTS between injured and healthy tendons became slightly more 
pronounced, ~10 N. UTS was tested on day 1, 3 and 7 after the last trauma, with small 
differences in UTS on day 1, 3 and 7. During the half year of pilot tests, the animals 
included were redundant from other projects at the laboratory, and the groups 
comprised 2–4 rats.
An irradiation dose of 3 J in this study was based on previous laboratory work in our 
research group. Preliminary data from an ongoing study with LLLT administered one
hour after collagenase injection presented less edema measured at 12 hour after 
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injection; an irradiation dose of 3 J provided superior results when compared to 1 J and 
6 J (now published in Marcos et al., 2011).
The laboratory where the investigations took place had a stable temperature of 24°C 
(SD ±2°C) and humidity 40% (SD ±10%).
The protocol for animal handling in study II and study III (Figure 3, p.38) was as 
follow:
Day 1: The animal was anesthetized with isoflurane (Isoba) using an Isotec vaporizer. 
The hair was shaved from both hind legs. Then animal’s right ankle was positioned in 
full dorsal flexion, and a tendon trauma was inflicted in a mini-guillotine where a 200 
g block with an edge 2 mm wide, dropped 20 cm. The trauma was located 9-10 mm 
from the plantar side of calcaneus, (Paper III, Figure 1). The trauma procedure took 30 
minutes to perform. Half an hour later the animal was again anesthetized and subjected 
to LLLT treatment: One point, 9-10 mm from the plantar side of calcaneus, was
irradiated with a dose of 3 J or a placebo dose (time corresponding to 3 J). The 
animal’s tail was marked for each action it went through.
Day 2: The procedures of anesthesia, tendon trauma and LLLT treatment were 
repeated fifteen hours after the first trauma.
Day 3: Twenty-three hours after the last trauma the animal was anesthetized, and in 
situ tendon thickness (including the peritendon) was measured in the right and left 
Achilles by RTUS. The Achilles area was screened both in longitudinal and 
transversal plane; two images were done on each tendon in each plane. Screening in 
the longitudinal plane was done with the whole length of Achilles in the image (Paper 
III, Figure 3). When screening the Achilles tendon and the adjacent structures in the 
transversal plane the probe was moved from the knee in a distal direction until the 
probe met the Calcaneus, and images were taken in this position.
The animal was again anesthetized two hours later, and given 0.4 ml intraperitoneal 
anesthetic (Mebumal 50 mg/ml; 1 ml contains 54.9 mg pentobarbital sodium, 400 g 
propylenglycol, 150 mg strong alcohol and distilled water to 1 ml). The animal was 
then euthanatized by cardiac arrest (1 ml saturated potassium chloride solution). 
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The skin overlaying the gastrocnemius muscle from calcaneus to the proximal part of 
the muscle was dissected free (Paper II, Figure 1). These skin flaps were utilized in 
study II.
The Achilles tendon was then released with scissors, and the muscle fibers were 
removed from the tendon with a sharp scalpel. The free tendon was sprayed with water 
containing 9% sodium chloride, placed in a small plastic bag labeled by a code for 
group identification, animal number and right/left side, and stored in a refrigerator at 
4°C. Three hours later tendons were subjected to UTS testing in MTS-820. Load and 
deformation data were sampled continuously during this test.
     
Figure 3  The experiment time schedule
The code for active- and placebo laser probe was not disclosed until the statistical 
analyses were done. The laser probe output was then measured to determine which 
probe had been the active one.
3.6 STATISTICS 
STUDY I
The differences in skin temperatures between the irradiation spot area and the 
neighboring control area on the index finger were used in analyses of thermal effects 
from LLLT irradiation. Analyses were done in subgroups, for each irradiation dose
and lasers.
Pearson´s correlation coefficients were calculated to determine relationships between 
irradiation doses and skin temperature. Student’s pairwise t-tests and ANOVA were 
used for comparison of statistical differences with a significance level set at p<0.05. 
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Microsoft Excel (Microsoft Office Excel 2007) was used for statistical analysis and 
graphics.
STUDY II
The energy penetrating through skin was calculated as percentage of the amount of 
energy that penetrated the plastic film measured immediately before skin penetration 
measurements. 
Descriptive statistical analyses on lasers’ average MOP, Student’s t-test p-value 
considered significant different, and graphs, at seven time-points, in four conditions, 
were done by Microsoft Excel (Microsoft Office Excel 2007).
Estimates of linearity in average response between six measured time-points 
(measurements at 10 seconds were omitted in these calculations) were analyzed by 
Statistical Package for the Social Sciences (SPSS, ver.19 for Microsoft) repeated 
measures ANOVA, Generalized Estimating Equations (GEE). The maximum 
likelihood estimate for linear response between measuring points of 30 sec intervals 
was calculated with 95% CI.
STUDY III
The difference in tendon thickness (including the peritendon) and UTS, between 
injured right Achilles treated with active LLLT, - placebo LLLT, and healthy left 
Achilles, were analyzed by paired t-test in SPSS (ver.18 for Microsoft). Microsoft 
Excel (Office 2007) was used for graphics. 
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4. SUMMARY OF RESULTS
 
STUDY I
The H0-hypothesis “There are thermal effects in human skin of high doses from 
infrared LLLT class 3B lasers, varying with irradiated dose and participants’ skin 
colour, age and gender” was confirmed, and the H1-hypothesis “There are no thermal 
effects from infrared LLLT class 3B lasers in human skin, regardless of irradiated 
dose and participants’ skin colour, age and gender” was rejected. 
The baseline skin temperature in the proximal part on the index finger after 
acclimatization was on average 30.7°C (SD ±2.8).
The laser probe tip temperature immediately after irradiation doses from 2 J to 12 J 
ranged from 30.1°C (SD ±2.2) to 33.7°C (SD ±3.4) for the 904 nm, 60 mW MOP
laser, and from 31.8°C (SD ±1.8) to 32.6°C (SD ±2.0) for the 810 nm, 200 mW MOP 
laser.
After placebo with an irradiation time corresponding to 2 J, the differences in skin 
temperature between the laser spot area and the control area were -0.9°C (SD ±0.7) for
the 904 nm laser, and -0.2°C (SD ±1.2) for the 810 nm laser. After the last dose in the 
sequence and the placebo with a time corresponding to 12 J, the temperature difference 
between the two areas was 0.4°C (SD ±1.2) for the 904 nm laser, and 0°C (SD ±1.1)
for the 810 nm laser.
All participants completed the six irradiation doses with the 904 nm, 60 mW MOP
laser. Participants with light and medium coloured skin completed all six irradiation 
doses with the 810 nm, 200 mW MOP laser with no reporting of any heat sensation. 
However, all participants with dark skin reported heat sensations during irradiation 
from both lasers. Eight of thirteen participants with dark skin withdrew from the 
experiment with the 810 nm, 200 mW MOP laser because they felt uncomfortable
heating in the irradiated area. Two of these participants withdrew during a 6 J 
irradiation dose (a dose recommended by WALT), four withdrew during a 9 J 
irradiation dose and two withdrew during a 12 J irradiation dose. Skin temperature at 
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the time of withdrawal showed a large variation among participants, possibly 
indicating considerable differences in heat pain tolerance (Paper I, Table 3).
There was a strong positive correlation between increasing irradiation doses and 
increased skin temperature for both lasers in all sub-groups (Pearson´s r = 0.98–0.99
when withdrawals were omitted from the analysis). 
The increase in skin temperature was significantly (p<0.01) higher in dark skin 
compared to light skin for all irradiated doses, regardless of laser type (Paper I, Figure 
3 and Figure 4).
Identical doses of laser irradiation resulted in significantly (pd0.001) higher skin 
temperatures in dark skin compared to light and medium coloured skin the 810 nm,
200 mW MOP laser (Paper I, Figure 4).
Irradiation doses of 2 J and 6 J with the 810 nm, 200 mW MOP laser induced a 
threefold increase in temperature of dark skin when compared to the 904 nm, 60 mW
MOP laser (Paper I, Figure 3 and Figure 4).
There was no significant thermal effect (pt0.16 for any comparisons) when irradiating 
with doses recommended in WALT guidelines (i.e. 2 J for 904 nm, and 6 J for 810 
nm), with temperatures increasing less than 1.5°C in light and medium coloured skin 
regardless of laser type. However, in dark skin there was a highly significant increase 
(p<0.0001) in skin temperature of 6.1°C (SD ±3.2) from a 2 J dose, and 9.2°C (SD
±4.5) from 6 J, with the 810 nm, 200 mW MOP laser. Irradiation with a 2 J dose using 
the 904 nm, 60 mW MOP laser also induced a significant (p=0.043) but non-painful 
increase in skin temperature of 1.9°C (SD ±1.8) in dark skin.
When equivalent irradiation doses of 6 J or more were administered to light and
medium coloured skin there were larger increases in skin temperature for the 904 nm,
60 mW MOP laser when compared with the 810 nm, 200 mW MOP laser (p<0.05)
(Paper I, Table 4).
There were no significant differences in skin temperature between males and females 
during laser irradiation in the dose interval of 2-12 J (no p-value lower than pt0.24). 
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Adjusting for skin colour by removing data for dark skin from the analyses did not 
affect this result (Paper I, Figure 5 and Figure 6).
There was a tendency toward higher skin temperatures in the irradiated area in 
younger participants (under 40 year of age) for both lasers, although comparisons with 
older participants just barely failed to reach statistical significance (pt0.06). There was 
tentative evidence that there were larger temperature differences between groups with 
higher doses for the 810 nm, 200 mW MOP laser than with doses recommended by 
WALT, and that the differences persisted when dark skin data was removed from the 
analysis (Paper I, Figure 7 and Figure 8).
STUDY II
The H0-hypothesis “A fraction of the optical energy from infrared LLLT class 3B 
lasers penetrates through rat skin during commonly used irradiation times” was
confirmed, and the H1-hypothesis “Optical energy from infrared LLLT class 3B lasers 
does not penetrate through rat skin during commonly used LLLT irradiation times”
was rejected.
Step one (no obstacle, through air only): The MOP from both lasers were stable
during the selected 150 sec of exposure. The 904 nm laser increased MOP by 0.3 mW 
(SEM ±0.4), while the 810 nm laser MOP dropped by 9.8 mW (SEM ±1.9) by the end 
of 150 sec of exposure time (Paper II, Table 1). 
The statistic GEE estimates a slope of 0.25 mW per 30 sec (95% CI: 0.07 to 0.42, 
p<0.01) for the 904 nm laser; and a slope of -1.14 mW per 30 seconds (95% CI: -1.44 
to -0.84, p<0.01) for the 810 nm laser. 
Step two (through plastic film): The plastic film reduced MOP during 150 sec of 
exposure by 3.6%, or 2.3 mW (SEM ±1.2), on average from the 904 nm laser; and by 
6.6%, or 12.7 mW (SEM ±1.0), on average from the 810 nm laser (Paper II, Table 1).
The statistic GEE estimates had the same trend as without any obstacle, but with a less 
steep slope, 0.16 mW per 30 sec (95% CI: -0.10 to 0.42, p=0.23) for the 904 nm laser; 
and -1.00 mW per 30 sec (95% CI: -1.49 to -0.52, p<0.01) for the 810 nm laser.
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Step three (through skin - probe in skin contact): Skin flaps from rat hind legs had 
thickness of 1.2 mm (SD ±0.2) (n=21). 
There was no difference between penetration through skin flaps from the left or the 
right hind legs (t-test values for the two lasers at seven time-points varies from p=0.63 
to p=0.91). 
The two lasers had statistically different skin penetration abilities. The percentage of 
energy penetrating through skin from the 810 nm laser, was stable at approximately 
20% of the MOP (ranging from 19.5% (SEM ±0.6) to 20.4% (SEM ±0.6) between 
seven measured time-points) during 150 seconds of exposure (Paper II, Table 1). The 
statistic GEE estimated slope for the 810 nm laser was -0.26% of MOP per 30 seconds 
(95% CI: -0.35 to -0.17, p<0.01). The percentage of energy penetrating skin from the 
904 nm laser increased almost linearly during 150 sec of exposure, from 38.7% of 
MOP (SEM ±1.4) to 58% of MOP (SEM ±3.5) (Paper II, Table 1 and Figure 2). The 
statistic GEE estimated slope was 2.29% per 30 sec (95% CI: 1.69 to 2.88, p<0.01) for 
the 904 nm laser. 
The two lasers had significant (p<0.01) different percentage of MOP penetrating 
through skin at all measured time-points (Paper II, Table 1 and Figure 2).
Step four (through skin - probe not in skin contact): Both lasers showed the same 
trends of energy penetrating through skin with the probe not in skin contact as the case 
was with the laser probes in skin contact. There were significant (t-test, p<0.01) 
differences in the percentage of MOP penetrating through skin with the probe not in 
skin contact from the two lasers at all measured time-points (Paper II, Table 1 and 
Figure 2). Even though, the slope of increased penetration during processing time from 
the 904 nm laser was smaller than with the probe in skin contact: The statistic GEE 
estimates a slope of 1.42% of MOP per 30 sec (95% CI: 0.82 to 2.03, p<0.01) with the 
probe not in skin contact. In percentages the amount of energy penetrating skin 
increased from 36.8% (SEM ±2.4) to 44.4% (SEM ±3.0) during exposure with the 904 
nm laser (Paper II, Table 1 and Figure 2).
The amount of energy penetrating through skin for the 810 nm laser was slightly 
higher during irradiation with the probe not in skin contact than with the probe in skin 
contact: The percentage of MOP was approximately 24% (ranging 23.1% (SEM ±1.7) 
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to 25.5% (SEM ±2.2)) during the exposure period with the probe not in skin contact 
(Paper II, Table 1 and Figure 2). The statistic GEE estimated slope was -0.42% of 
MOP per 30 sec (95% CI: -1.27 to 0.43, p=0.33). 
Irradiation with the laser probe in skin contact versus not in skin contact resulted in
changes in skin penetration ability for both lasers. These changes are most likely not 
attributed to the optical laser parameters, but to the different physical shape of the two 
probe tips. The 904 nm laser probe has a convex protruding lens, which squeezes the 
skin when the probe is in skin contact. This will cause better penetration with full skin 
contact than with no skin contact. On the contrary the 810 nm laser probe has a flat 
folded up lens. Here the metallic ring surrounding the lens will gather and push skin 
underneath the lens, which leads to less penetration with the probe in skin contact than
not in skin contact (Paper II, Figure 3).
STUDY III
The H0-hypothesis “A single LLLT dose, after an acute tendon trauma, has biological 
effects on the injured tissue” was confirmed, and the alternative hypothesis “There is 
no effect from a single LLLT dose after an acute tendon trauma” was rejected. 
Achilles tendon thickness (including the peritendon) measurements in the longitudinal
plane by RTUS revealed a statistically significant (p<0.05) difference between the 
injured right Achilles and the healthy left Achilles, in the active-LLLT group. In the 
group treated with placebo-LLLT, tendon thickness (including the peritendon) side 
differences were insignificant (p=0.35). The mean Achilles thickness (including the 
peritendon) on the injured right tendon was 0.93 mm (SD ±0.03) in the active-LLLT 
group, and 0.73 mm (SD ±0.07) in the placebo-LLLT group. The healthy left Achilles 
had a mean tendon thickness (including the peritendon) of 0.69 mm (SD ±0.07) and 
0.70 mm (SD ±0.10) respectively. 
The difference between injured right-Achilles and healthy left-Achilles on transversal 
plane RTUS images was significant at (p<0.05) in the active-LLLT group. In the 
placebo-LLLT group transversal tendon thickness side difference was insignificant 
(p=0.16). The mean transversal thickness of the injured right Achilles was 0.70 mm 
(SD ±0.10) in the active-LLLT group, and 0.63 mm (SD ±0.14) in the placebo-LLLT 
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group. The mean tendon thickness of the healthy left Achilles in the two groups was 
0.51 mm (SD ±0.07) and 0.57 mm (SD ±0.07) respectively. 
There were no significant differences in UTS between the injured right Achilles and 
healthy left Achilles in the active-LLLT group and in the placebo-LLLT group. The 
mean UTS in the injured right Achilles was 51.11 N (SD ±9.77) in the active-LLLT
group, and 57.64 N (SD ±7.80) in the placebo-LLLT group. The healthy left Achilles
had an UTS of 53.94 N (SD ±9.80 N) in the active-LLLT group and 59.66 N (SD 
±11.86 N) in the placebo-LLLT group. 
Two months later we wanted to ensure reliability and measured tendon thickness again 
on the stored longitudinal images. This revealed an intrarater reliability by ICC(1,1) 
ranging from 0.68 to 0.83 (unpublished data), indicating moderate reliability.
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5. DISCUSSION
This chapter contains sections with general discussion, methodical discussion, further 
research with pertinent follow-up studies, and finally conclusions.
5.1 GENERAL DISCUSSION
This general discussion will focus on the thesis in relation to perspectives of the 
current project and the physiotherapy research literature, biophysical effects from 
LLLT in skin, LLLT doses and initiating LLLT after acute trauma, and animal models
in tendinopathy.
5.1.1 PHYSIOTHERAPY RESEARCH
Society is constantly changing and this requires health professionals’ to adapt to 
changing demands in the society. Physiotherapists are an important resource available 
to society’s health professionals. They shall always provide the most suitable 
examination and treatment methods which are best for helping the patients. To meet 
this requirement research in physiotherapy has increased in recent decades, with more
emphasis on evidence-based practice and clinical research (Coronado et al., 2011). The
number of RCTs and systematic reviews in physiotherapy published in the 
Physiotherapy Evidence Database (PEDro) increased almost exponential during the 
period from 1960 to 2009 (Moseley et al., 2002), and constitutes now more than 23 
thousand papers (PEDro, 2013). In line with this increase the quality of RCT of 
physiotherapy interventions has improved. Since 1960, study’s quality score (PEDro 
score 0-10, where10 is best score on trials internal and external validity) has increased 
by on average 0.6 points per decade (Moseley et al., 2011). Similar efforts on improved 
evidence-based knowledge have also taken place in research on LLLT. There has been 
a sharp increase in the number of animal studies on LLLT since the turn of the twenty-
first century (Figure 4). A search in PubMed on the terms “animal” and “low level 
laser therapy” resulted in almost a thousand papers.
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Figure 4 Publications over time on “animal and low-level-laser-therapy”, (search in GoPubMed.com, April 2013)
 
(GoPubMed, 2013) 
In clinical practice physiotherapists use electrophysical devices both in examination of 
patients and as part of a combined physiotherapy treatment package. Physiotherapists 
are capable of performing clinical examinations to guide clinical reasoning for optimal 
timing and optimal combination of treatment modalities. But physiotherapists are not 
necessarily in-depth specialists in the bordering sciences of physics, physiology or 
radiology. Still, physiotherapists must sometimes perform scientific research in
bordering disciplines when it is necessary to elucidate what mechanisms are at play 
that causes effects from the various EPAs used by the physiotherapy profession. This 
kind of translational research has been sparse in physiotherapy science, partly because 
of physiotherapists´ limited competence in basic science research. The solution to this 
is of course to initiate collaboration with other researchers in medical and basic 
sciences. In this perspective, the project at hand is an example of translational research 
involving a number of disciplines other than physiotherapy. 
This project has involved acquisition of new skills that were needed for the realization 
of the research project. I have acquired skills in imaging techniques such as 
ultrasonography, thermography and gained qualification for performing laboratory 
animal studies (Federation of European Laboratory Animal Science Associations, 
FELASA C-course). An additional benefit from the research project is the 
confirmation that physiotherapists may be able to acquire these additional skills and to 
handle them professionally with adequate reliability.
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5.1.2 LLLT’S BIOPHYSICAL EFFECTS IN SKIN 
The various EPAs used in physiotherapy interventions are designed to deliver different 
forms of energy to the human body in a therapeutic purpose. Therapeutic lasers deliver 
light energy to the human skin in order to trigger phototherapeutic reactions in 
underlying tissues. With the first clinical LLLT studies being published in the 1980s
critics soon claimed that the doses used were too low to evoke any noticeable thermal 
or biological reactions in the human body (Devor, 1990). In the nineties knowledge 
improved about the biophysical properties of LLLT irradiation. More studies into basic 
mechanisms led to a different understanding of LLLT effects, which shifted the 
prevailing perspective to attribute possible LLLT effects to non-thermal mechanisms 
(Basford, 1995). This perspective may have been challenged by the recent technological 
developments. New and more powerful class 3B laser devices have been brought to 
the market by laser manufacturers claiming that “more is better”. Theoretically this has 
re-opened the possibility that thermal effects may be present during LLLT irradiation.
The thermal effects in human skin from infrared class 3B lasers, observed in study I, 
indicate that laser MOP is an aspect to be considered in clinical settings. The skin
temperature increases in a near-linear manner with LLLT irradiation dosage. This 
dose-temperature relation seems to apply for all combinations of lasers and participant 
subgroups (age groups, gender and skin colour). The results show that the biophysical 
effect, heat production, in human skin during irradiation from infrared lasers is 
strongly related to skin colour. Skin temperatures were significantly higher at all 
irradiation doses for participants with dark skin compared to other skin colour groups, 
regardless of laser type. This indirectly indicates a differential influence of light 
energy absorption as lesser energy seems to be absorbed in light and medium coloured 
skin than in dark skin. Similarly skin colour dependent absorptions has previously 
been found in studies with ultraviolet irradiation, where darker skin was found to act
as a better photon absorber and photo protection barrier than lighter skin (Giacomoni, 
1995; Taylor, 2002; Yamaguchi et al., 2007).
One could be tempted to assume that the observed thermal effect from LLLT solely 
was a result of irradiated power density (mW/cm2), but this was not the case. The 810 
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nm laser with more than three times as high power density as the 904 nm laser induced 
less thermal effect in light and medium coloured skin.
Although both lasers evoked similarly shaped thermal responses for irradiation doses 
(J) in the graphs (Paper I), there were other factors that differed.  The irradiation time 
with the 904 nm was more than three times longer as it was with the 810 nm laser for 
equal doses to be delivered. The longer exposure time component might have caused 
slightly higher skin temperatures from equal doses in light and medium coloured skin 
from the superpulsed 904 nm laser than from the continuous 810 nm laser. 
Aging of the human skin-structure changes during the lifespan and could possibly 
influence the biophysical penetration properties for infrared class 3B lasers. Even 
though there was a tendency to more heat production in younger skin (under 40 year of 
age) than in older skin (over 60 year of age), these differences in skin temperatures 
were small and not significantly different between the three age groups included in 
study I. Although, a type-II error caused by few participants in the oldest age group 
cannot be ruled out. 
Another possible factor influencing biophysical penetration could be gender. A gender 
difference in sun-sensitivity has previously been reported in the literature, with female
skin being more sun-sensitive than male skin (Guinot et al., 2005). However, these gender 
differences seem to be of lesser importance, as we found no significant differences in 
the biophysical heating effects in human skin, between genders during irradiation from 
the two infrared class 3B lasers in study I.
Laser irradiation with doses recommended by WALT resulted in small and 
therapeutically irrelevant temperature changes (<1.5°C) in light and medium coloured 
skin. But the observed temperatures in dark skin with doses at, or above, 2 J for the 
810 nm laser exceeded the threshold for painful thermal stimuli (Defrin et al., 2002). The
significant heating of dark skin caused by the 810 nm, 200 mW MOP laser has 
implications for irradiation safety, and indicates that lasers with MOP in the 2-300 
mW range should probably not be used clinically with doses at and above 6 J in 
persons with dark skin.
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A previous penetration study using LED with an infrared wavelength Ȝ  QP
found decreased light transmission in skinfolds in participants with dark skin, but no 
significant differences between groups of different skin colours (Nussbaum et al., 2007).
However, the power density for the LED source was very low compared to our study 
and used only 1-2% of the power density used in our study I. Additionally, both ours 
and their study only included respectively 13 and 15 participants with the darkest skin 
colour in the sample, and consequently type-II errors cannot be ruled out.
The biophysical ability of irradiation from infrared class 3B lasers to penetrate through 
skin was larger than expected from previous studies, as between twenty and fifty 
percent of the irradiated energy penetrated. The biophysical effect time-profile was 
expected to show a constant amount of energy penetrating through the skin with 
commonly used irradiation times for both lasers. Small differences between the 810 
nm and 904 nm lasers were expected as longer wavelengths have been shown to 
penetrate slightly better (Ackermann et al., 2002; Bashkatov et al., 2005). However, only the 
continuous 810 nm laser showed a constant amount of penetrating light over time. As 
expected, we initially observed that a greater amount of energy penetrated through rat 
skin from the 904 nm laser than from the 810 nm laser. But the observed 50% increase 
of penetrating energy during the irradiation period from the superpulsed 904 nm laser 
was unexpected and can probably not be explained by wavelength differences alone. A 
biophysical effect time-profile of gradually increasing skin penetration during 
exposure has not previously been reported in the LLLT literature. 
Increased skin penetration during exposure due to photobleaching is a phenomenon in 
the PDT literature. Photobleaching is the photochemical destruction of fluorescent 
molecules which consequently reduces the auto-fluorescence of the tissue and thereby 
causes lesser absorption of light. PDT utilize a photosensitizer in combination with 
light and tissue oxygenation in cancer treatment (Dougherty et al., 1998), and the 
photobleaching effect in skin is derived from the photosensitizer (Georgakoudi et al., 1997;
Zhu and Finlay, 2008). This makes it inexpedient to extrapolate photobleaching results from 
the PDT literature to our findings. Although, reduced fluorescence in skin during laser 
irradiation was found in a recently published study on improving skin Raman spectral
quality. Wang et al. (2012) found a fluorescence decrease in human skin of 
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approximately 25% during 200 sec of exposure from a 785 nm laser with power 
density 0.29 W/cm2. This percentage is somewhat lower than our findings from the 
904 nm laser. The effect from irradiation modes, continuous versus superpulsed (peak 
power 12.5 W) was compared in a study on enhanced melanin fluorescence (Kerimo et 
al., 2011). Irradiation from a 930 nm laser with approximately the same MOP in 
continuous mode and superpulsed mode showed only small differences in activation of 
enhanced emission, which indicates that irradiation mode play a minor role in 
enhanced melanin fluorescence. As discussed, it cannot be said with certainty to what
extent this photobleaching observed from the superpulsed 904 nm laser in study II 
occurred due to irradiation of this particular wavelength and/or the combination of 
pulse parameters (peak power, width and frequency) compounded in this superpulsed 
laser or other factors. 
The few published LLLT penetration studies either use mathematical modelling or 
register outcome only for a single time-point. These models make the inherent 
assumption that penetration is constant and independent of time. In our study II we 
decided to investigate not only penetration at a single time-point, but to characterize 
the time-profile for LLLT skin penetration. In this novel area of research, we found it 
prudent to start by using an in vivo model. However, we recognized that further in situ 
experiments are needed in order to verify the presence of the observed penetration 
variation with superpulsed lasers in clinical settings.
It would be of greater clinical value to pursue the question of skin penetration further 
by measurements in an in situ experiment. This would require a more sophisticated 
technical procedure with smaller and more advanced optical sensors placed 
subcutaneously in a surgical procedure in the living subjects. Due to the inherent 
scattering and backscattering of laser light when passing the skin barrier and different 
layers of tissue, the optical sensors would also need to be circularly shaped to detect 
photons from all directions and connected by a thin optical fibre. A natural extension 
of study II would be to initiate a new in situ experiment if possible with suitable 
sensors, and test if acceptable reliability can be achieved. Finally, with positive results 
in the in situ experiment one could extend this research further to an in situ human 
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experiment with a sensor surgically placed in, for instance, the peritendinous tissue of 
the Achilles tendon in volunteers, if this would be acceptable to the regional ethical 
committee. Whereas study II only gives us an indication of the possible relative 
penetration of LLLT in rats, the above delineated studies if feasible would have shed 
more precise information on LLLT penetration in human clinical settings.
5.1.3 LLLT DOSES AND INITIATING LLLT
Understanding the LLLT parameters is a challenging exercise for clinicians. 
Therapeutic lasers are characterized by a complexity of parameters comprising 
wavelength, output power, spot size and irradiation mode. Additionally, irradiation 
time seems to play a role, as longer exposure time seems to be more effective than 
short exposure time (Castano et al., 2007). The optical energy in the laser beam is gradually
being absorbed by the tissue it penetrates. Biological tissue can only utilize a certain 
amount of optical energy, inasmuch as there are no known depositaries for optical 
energy in biological tissue. This means that irradiation time may have a direct 
influence on the effectiveness of LLLT irradiation in the biophysical processes taking 
place in tissue.
There is strong clinical evidence reflected in the WALT dosage guidelines that 
superSXOVHG Ȝ  QP ODVHUV KDYH ORZHU RSWLPDO GRVH UDQJHV LQ PXVFXORVNHOHWDO
GLVRUGHUV WKDQ FRQWLQXRXVȜ QP ODVHUV (Tumilty et al., 2010; Jang and Lee, 2012). It has
been proposed that less energy is lost in the skin barrier with the superpulsed 904 nm 
laser than with the continuous 810 nm laser (Bjordal et al., 2003b). The superpulsed 904 nm 
laser has both a wavelength-dependent initial larger proportion of energy penetrating 
through the skin barrier, and increased penetration during irradiation. Calculations on 
the basis of our findings in study II show that both a 4 J dose from the 810 nm laser 
and a 2 J dose from the 904 nm laser bring a similar energy dose of 0.8 J through the 
skin barrier. Consequently, our results from study II support the differentiation 
EHWZHHQ GRVDJHV IURP Ȝ  QP DQG Ȝ  QP ODVHUV LQ :$/7 GRVDJH
recommendations.  
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In study III rat Achilles tendons were irradiated by a dose of 3 J after injury. An  
irradiation dose of 3 J is commonly used in clinical practice for human inflammatory 
conditions and has been adapted from the dose recommendations from WALT (WALT, 
2010). It is unclear if LLLT parameters which are effective in humans also can be 
extrapolated to small rodents. In retrospect, it seems that effective doses in animal 
studies are somewhat smaller than in humans (Bjordal et al., 2006a), and we may have gone 
too high in dosage for rat Achilles tendon pathology.
Recent studies ZLWK ///7 Ȝ  QP DQG GRVHV RI  - DQG  - following a 
collagenase-induced tendinitis in rat Achilles evaluated biophysical and biomechanical 
aspects of the tendons. They found a single dose of 3 J to be most effective for 
reducing edema significantly 12 hours after injection (Marcos et al., 2011), while the 1 J 
dose had better UTS values in tendons 7 days after injury (Marcos et al., 2012).
In another recent study with LLLT (Ȝ QPdoses of 0.1, 0.3, 1.0 and 3.0 J were 
used to see if prevention of skeletal muscle fatigue and muscle damage in rats could be 
achieved. All irradiated groups except the 3.0 J group showed significantly lower post-
exercise creatine kinase activity than the control group immediately after the electrical
muscle contraction tests (Leal Junior et al., 2010). Thus, optimal irradiation doses from 904 
nm lasers in rat muscles seem to be closer to 1 J, and we may have over-dosed with 3 J
in our study III. This could explain the non-significant differences, but possibly not the 
increased edema observed in the active-LLLT group.
A more likely explanation of the increased edema in the active-LLLT group could be
the early initiation of LLLT after injury. Timing the initiating of LLLT after an injury 
has not been subject to extensive debates in the literature. But in animal studies 
measuring edema after inducing an injury, LLLT is typically administrated an hour or 
later (Albertini et al., 2004; Albertini et al., 2007; Bortone et al., 2008; Marcos et al., 2011). It is also 
conceivable that LLLT treated tendons (on day one of the experiment) might be more
vulnerable than untreated tendons to a trauma on the next day. 
Hence, a possible negative effect on edema development in inflamed tissue may be
restricted to the first half hour after the onset of inflammation (MacKenna et al., 1998; Kyaw 
et al., 2001; Arnoczky et al., 2002; Werle et al., 2002). In this perspective, our findings may have
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important clinical implications as it has been an open question when the earliest time-
point for effective LLLT of soft-tissue injury might be.
It is interesting to note that increased tendon thickness is exhibited irrespective of the 
state of the tendinopathy being in an acute or a chronic phase. In the acute stage of 
tendinopathy edema may be present in the paratenon or tenosynovia, or 
intratendinously with loosening cross-links, but without major defects in the 
longitudinal tendon morphological structure. Increased tendon thickness may also be 
related to the formation of intratendinous edema after overload or trauma in a partly 
degenerated tendon (Kongsgaard et al., 2005). After the initial edema partial ruptures of the 
longitudinal fibre bundles will typically heal with tendon hypertrophy caused by the 
increased collagen fibre formation during the proliferative phase of tendon repair 
(Gerriets et al., 1993; Khan et al., 1999; Sharma and Maffulli, 2005b; Fillipin et al., 2005). In this 
perspective, increased tendon thickness may be present in the early phases due to 
edema, while tendon hypertrophy may be the cause of increased tendon thickness in 
later remodelling stages of partial rupture tendinopathy.  
5.1.4 LLLT IN TENDINOPATHY - ANIMAL MODELS 
Human tendinopathies have a multifactorial aetiology, and research in human 
tendinopathies is complex with ethical limitations on evaluation methods (Cook and Khan,
2007). Animal models can never be fully fledged models for human tendinopathies, but 
they may be useful in reproducing some aspects of human tendinopathy. Behaviour 
and nutrition can be controlled more easily in animal studies than in human studies.
This gives animal studies an edge in being particularly suitable for single-factor 
experimental design. Another advantage of animal models is that they allow full tissue 
evaluation of biomechanics properties, histopathology and morphology; although the 
latter two were not used in this particular project. 
The use of animal models in research on tendinopathies also has its´ limitations.
Extrinsic risk factors, like equipment and environmental conditions, are associated 
with human tendinopathy. These factors are difficult to imitate in animal models and 
restrain use of animal models as true triggers of tendinopathies in the way they occur 
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in humans (Lui et al., 2011). There are also obvious anatomical differences between 
bipeds and quadripeds. This affects the validity of using animal models in 
tendinopathy research and limits extrapolation of findings in animal studies to human 
tendinopathies (Warden, 2009; Lui et al., 2011).
One animal model for mimicking tendinopathy has been used by inducing repetitive 
mechanical stress. This over-use model forces animals to run daily for 1 kilometre in 
60 minutes, causing development of changes in cellularity, tendon thickness and some
40% reduction in tensile strength in supraspinatus tendons (Soslowsky et al., 2000). In other 
studies with this over-use model, findings of inflammation and fibre degeneration have 
been conflicting. Perry et al. (2005) found significant presence of inflammatory 
markers, while Archambault et al. (2007) found little inflammatory reactions or 
degeneration, but a switch in procollagens to type II and III. 
The mechanical model where a blunt trauma is inflicted to tendons in a mini-guillotine 
is fairly new in mimicking tendinopathy. In previous studies, a standardized trauma in
the mini-guillotine caused distinct histopathological changes in rat tendons (Fillipin et al., 
2005; Salate et al., 2005; Oliveira et al., 2009).  But is has been an open question how this may 
affect biological properties of the tendons. During our pilot testing we achieved 
differences in UTS between healthy and injured rat Achilles tendons of ~10 N. 
Nevertheless UTS differences only came to 2-3 N in study III. A new rat study has 
since our study was performed found that the ability to regain normal UTS following 
tendon injury decreases with age (1, 3 and 12 months) (Lavagnino et al., 2013). This age-
related regeneration ability in rat tendons can possible explains the relative low UTS 
differences found in our study III as we used younger rats (1-2 months) in study III
than in the pilot tests (6-12 months).
56 
 
5.2 METHODICAL DISCUSSION
In this section the methodological aspects of this project’s design, procedures,
subjects, instruments, data and statistics will be discussed. Methodological limitations 
are included in the sub-sections.
5.2.1 DESIGN AND PROCEDURES
The repeated measurements design is a strong design as it is especially sensitive in 
detecting differences in the same subject between conditions measured. In study I 
biophysical effects from several doses of LLLT irradiation were compared to a control 
area in the same body part of the subject, which means that subjects were their own 
controls. This minimizes the possibility of other factors than LLLT causing the 
changes in biophysical effects between the two measured areas. In study II the 
biophysical ability of energy from LLLT irradiation to penetrate through rat skin, was 
compared at several time-points during exposure. 
There is consensus that randomized controlled double blind trial is the best suited 
experimental design for evaluating effects from an intervention. In study III the effect 
on edema formation and UTS from active-LLLT versus placebo-LLLT after an acute 
tendon trauma was investigated. The animals’ contralateral healthy tendons served as 
controls.
Controlled manipulation of a variable enables us to infer something about the causality 
of the observed changes under study, although the strength of the conclusions depends 
on the level of control in the studies. The researcher can achieve control by uniformly 
implementing the independent variable, eliminating extraneous variables from the 
setting and relating to subjects, ensuring the reliability of measurements, and limiting 
information provided to themselves and subjects (Domholdt, 2005). All three studies in 
this project were provided with detailed protocols and standardized procedures. The 
implementation of the independent variable, irradiation doses (in study I and III) and 
exposure time (in study II), was specified in advance. Extraneous excitation was
reduced by use of a highly controlled environment, subjects as their own controls, and 
by measuring outcome data at one occasion. Information to subjects and researchers 
57 
 
was limited where possible: Subjects in study I were blinded to the irradiation 
sequence i.e. active doses and placebo. Researchers in study III were blinded to 
placebo/active LLLT intervention. 
LIMITATIONS TO STUDY I
One limitation to study I was that the irradiation doses were delivered in a fixed 
sequence. Applying the selected doses in a randomized manner would have revealed if 
this possible confounder was at play. The skin-contact laser irradiation application 
technique and the thermographic measurement seemed to be fairly insensitive to 
operator and observer variability. 
Pilot testing of intraobserver and interobserver reliability could have been included.
This would have made the study more robust by quantifying the variability and 
possibly eliminating this potential source of bias. All testing measures of outcome for 
each subject were done on a single occasion. We could have repeated the test 
sequences on another day to ensure that an acceptable intrasubject test-retest reliability 
level was achieved.
LIMITATIONS TO STUDY II
Considering that LLLT is an intervention used in clinical practice on humans, one 
limitation to study II was irradiation performed in rat skin with an in vivo procedure.
On the other hand, for clinical problems (in situ) an in vivo experiment is often 
considered suitable as a first stage for investigating if a specific mechanism may or 
may not be at play.
LIMITATIONS TO STUDY III
The intervention of LLLT irradiation in study III was set to half an hour after trauma.
In hindsight, it is easy to see that more groups with administration of LLLT at other 
time-points after an acute trauma could have shed light on the optimal timing of LLLT 
treatment after a trauma. But these results were unexpected and difficult to foresee. 
Future experiments with this model should include different time-points for irradiation
and different irradiation doses.
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Another amendment to the design of study III would be to broaden it with groups 
treated with the 810 nm, 200 mW MOP laser. By doing so parallels to differences in 
laser effects found in study I and study II could have been drawn.  
The design of study III would have been more robust if we had provided pre-trauma 
test measurements on RTUS tendon thickness. This would have allowed comparison 
of pre- and post-trauma measurements on the same tendon, which is a variable of less 
variability than using our comparison to the contralateral control. Additionally, 
pathohistological outcome measurements subsequent to the double mini-guillotine 
trauma would have brought supplementary information about the tissue pathology. But 
our choice of UTS as outcome measure precluded the possibility for making a 
histological analysis of the actual tendons. 
5.2.2 SUBJECTS
The research question for the Thesis was to look into biophysical and biological 
effects from LLLT lasers in tissue. The target tissue was the skin in study I and study 
II, and tendons in study III. The subjects under study act as a proxy for the target 
population of interest. Researchers use information from a sample of subjects to make 
some inference about the wider population of interest (McAuley, 2003).
The sampling method, probabilistic sample, involves randomization and is preferable 
when the researcher hopes to generalize findings from a sample. Nonprobability 
samples have absence of randomization and tend to have more sampling error than 
probability samples (Domholdt, 2005). The healthy humans in study I were recruited by 
nonprobability sampling, as a stratified convenience sample. This recruitment method 
can limit the generalization of the findings, but when subjects are compared to 
themselves the results will still yield clinical relevance. Power analysis was not done 
as any similar studies on thermal effects from LLLT lasers on human skin were not 
found in the literature, and the expected variation is a crucial factor in power analyses. 
The limited sample size of forty subjects leads to small numbers in some of the 
subgroups. This may have caused type II statistical errors in comparisons of 
subgroups. A type II error typically occurs when the statistical analysis results in no 
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differences between groups when in reality there is a small but true difference. A
larger sample could have shed light on whether the observed trends in age subgroups 
were occurring at random or not. 
In study I we chose the dorsal side of the proximal phalanx of the right index finger for 
laser irradiation. A consideration regarding the anatomical location used for laser 
irradiation in study I includes the variety of actual sites for LLLT treatment in clinical 
practice. Therapeutic lasers are commonly used for treatment of tendons and joint 
disorders. Several tendons and joints in the hand have been subjected to LLLT in 
clinical studies (Sharma et al., 2002; Ozkan et al., 2004; Ye et al., 2011). Additionally, skin exposed 
to sunlight develops adaptation and enhances photo-protection to a higher degree than 
skin usually covered from sunlight (Alaluf et al., 2002). In this perspective laser irradiation 
in the skin of the hand can be expected to be absorbed more and penetrate less than in 
other anatomical locations. 
There was a high withdrawal rate (62%) of participants in the dark skin group during 
irradiation with the 810 nm, 200 mW MOP laser. This weakens the precision of the 
exact mean temperature increase in dark skin caused by the lasers. However, it can be 
argued that this value is of purely academic interest and beyond the scope of this 
project. The important clinical finding is that painful temperature increases occur 
during LLLT irradiation with a 200 mW, 810 nm laser in dark skin. This also implies 
that the great absorption of laser energy in dark skin probably makes the remaining 
penetrating energy insufficient to induce photobiological reactions in deeper tissues. 
As a curiosity, one participant with dark skin and a research background wanted for 
his own interest to measure how high a painful increase in skin temperature he could 
tolerate (relative to the control area). The skin temperature increased by 11.2°C during 
a dose of 2 J, and 22.3°C during a dose of 6 J (irradiation was interrupted by the 
investigators and he was not irradiated with doses of 9 J and 12 J). 
Animals included in study II and study III are inbred for more than 20 generations, and 
of inbreeding coefficient >98%. This increases homogeneity of the animals, and 
reduces intrasubject variability in tissues such as skin and Achilles tendons. Animals 
were given 10 days of acclimatization in the laboratory before the experiments were 
started.
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In study II in vivo rat skin overlaying the gastrocnemius muscles from 34 animals was 
harvested. Six of these skin flaps were discarded because of human errors in the 
dissection procedure. As an extension of the results in study I, and with the knowledge 
we have after completing study II, it would have been of great value for clinical 
practice to investigate infrared class 3B lasers ability to penetrate human skin in 
different colours and age groups.  
In study III sixteen animals were randomized to two groups of 8 animals. During the 
experiment there were no waivers. The target tissue in study III was in situ and in vivo
rat Achilles tendons.
5.2.3 INSTRUMENTS
In this project electrophysical devices were used for both intervention and outcome 
measurements. 
Both intervention devices, i.e. the 810 nm, 200 mW MOP laser and the 904 nm, 60 
mW MOP laser, had stable MOP during exposure time as measured in study II (Paper 
II, Table 1). The active LLLT probe in study III was measured for control 
subsequently to study III with the same MOP stability as the probe used in study I and 
study II.
For the measurements of biophysical and biological effects from LLLT in tissue we 
used other electrophysical devices. The biophysical effects in skin were measured as 
heat by the Flir system, ThermaCAM S65HS, and as the amount of penetrated energy 
by the Optical Power Meter system. The biological effect in tendons were measured as 
tendon thickness (including the peritendon) by a RTUS device manufactured by 
General Electric, named Logiq e, fitted with a 12 MHz linear probe. The 
biomechanical testing of tendon UTS was performed with a pulling devise called 
MTS-820. 
THERMOGRAPHIC IMAGING
Thermographic imaging has been used in medicine since the sixties. Technological 
improvements during the eighties and nineties have made thermographic cameras 
more accurate and made this type of imaging less time consuming. Today’s 
61 
 
thermographic cameras have a small error rate of only ± 2% and typical precision with 
deviation of less than 0.1°C when measuring skin temperatures (Villaseñor-Mora et al., 2009;
Jiang et al., 2005). One limitation for thermography used as an outcome measurement in 
medical science has been the adaption of biological systems and the method’s inherent 
sensitivity to environmental temperatures. Consequently, thermographic imaging
should be performed in a temperature controlled environment where ambient 
temperature during measuring sessions does not vary more than 1°C (Jiang et al., 2005). In 
study I the laboratory temperature varied less than 0.5°C during the period of data 
collection.
Materials have different abilities to emit thermal radiation, expressed as a material’s 
emissivity with range from 0 (not emitting) to 1 (complete emitting). Thermographic 
cameras visualize energy emitted from materials, and they are most sensitive to 
temperature changes in materials with high emissivity. Human skin on the back of the 
hand has an emissivity of 0.98, and skin pigmentation does not affect this value (Ring, 
2006; Villaseñor-Mora et al., 2009). The Flir ThermaCAM S65HS used in this project is 
FDOLEUDWHG RQFH D \HDU DJDLQVW D EODFNERG\ HPLVVLYLW\ İ  GLVWDQFH  PHWHU
Calibration is based on the International Temperature Scale (ITS-90) and performed at 
the Swedish National Testing and Research Institute.
There are no studies found in the literature on reliability tests of the ThermaCAM 
S65HS. 
OPTICAL POWER METER
The Optical Power Meter in study II was a ThorLabs model PM100 fitted with a 
S121B optical sensor. The wavelength-specific measurement mode was operating at 
five specific wavelengths; 635, 670, 780, 810 and 904 nm. For our experiment, the two 
wavelengths (810 nm and 904 nm) that corresponded to the LLLT lasers were used.
Laser power meters are known for having high stability and low measurement errors, 
but earlier equipment has been flawed by variations in the absolute values obtained 
during laser radiant power measurements (Nussbaum et al., 1999). For the purpose of study
II, we were less interested in the absolute radiant power of the lasers, but more in the 
stability of the laser MOP and their relative loss of energy over time when passing 
through the skin barrier.    
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REAL TIME ULTRASONOGRAPHY 
In a previous study from our research group, we found that intrasubject side 
differences in tendon thickness on RTUS were more reliable than intersubject 
variations in tendon thickness, as measures of tendon disorders (Bjordal et al., 2003a). The 
RTUS device used in this project, a GE Logiq e, with a 12 MHz linear probe, has 
present high interrater reliability and intrarater reliability in Master-thesis on human 
shoulder tendons thickness (Ingebrigtsen, 2012; Naterstad, 2012) and on median nerve cross-
sectional area in human carpal tunnel (Hummelsund, 2008).
ULTIMATE TENSILE STRENGTH
Biomechanical testing of UTS is an evaluation method which has been commonly 
used in experimental tenotomy studies (Forslund and Aspenberg, 2001; Forslund et al., 2003;
Dimmen et al., 2009). Nevertheless UTS testing after tendon trauma induced by a mini-
guillotine has, to our knowledge, not previously been reported in the literature. A 
major technical challenge in UTS testing of healthy rat Achilles tendons has been to
obtain a reliable, non-sliding grip of the proximal end of the tendon. We have only 
found two papers investigating UTS of normal tendons, possibly because investigators 
have experienced grip slippage and consequently test failure before the tendon 
ruptured.
During UTS testing in study III most tendons ruptured a few mm from the distal grip 
zone with forces up to 75.2 N. In this model even healthy rat Achilles tendon UTS can 
be measured. One aspect of the results in study III is the relatively wide standard 
deviation (SD) we found for UTS in rat Achilles tendons. Whether this SD reflects the 
natural variation of rat Achilles UTS or is a consequence of the procedures used for 
UTS testing is as yet unclear.
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5.2.4 DATA
The photo-protection ability of the skin barrier is of relevance when exploring effects 
from LLLT. The energy from LLLT has to pass the skin barrier to influence 
physiological processes in underlying tissues. Melanin is a chromophore in human 
skin which provides photo-protection from sunlight by absorbing photons (Giacomoni, 
1995; Taylor, 2002)DQGZLWKDWKHUPDOUHOD[DWLRQWLPHRIaȝVHF(Stratigos and Dover, 2000).
The protective role of melanin against UV radiation is well known (Kaidbey et al., 1979;
Costin and Hearing, 2007; Brenner and Hearing, 2008), but the specific characteristics by which
the skin filters infrared irradiation are poorly described. The photon protective
processes in skin include absorption and conversion of irradiated energy to heat 
energy. 
The biophysical parameters as heat and skin penetration time-profile are of scientific 
value as no studies so far have dealt with these effects from infrared class 3B lasers. 
Even though heat induction in skin is an indirect effect of LLLT irradiation, this 
parameter still provides information about differences related to skin colour, age and 
gender (study I). The amount of energy penetrating skin during exposure is an 
essential figure in customizing doses for treating tissue beneath the skin (study II).
The biological parameter edema provides a rough estimate of the ongoing processes 
after an acute tendon trauma. When trauma is followed by treatment (placebo-/active 
LLLT) the difference in edema between the two groups will reflect the active 
ingredient of LLLT. The biomechanical parameter UTS is of interests as tensile 
strength reflects tendons’ main in situ properties (study III). 
It is interesting to note that increased tendon thickness is exhibited irrespective of the 
state of the tendinopathy being in an acute or chronic phase. In the acute stage of 
tendinopathy, edema may be present in the paratenon, tenosynovia or intratendinous 
with loosening cross-links but without defects in the longitudinal tendon structure
(Couppe et al., 2009). Increased tendon thickness may also be related to the formation of 
intratendinous oedema after overload or trauma in a partly degenerated tendon 
(Kongsgaard et al., 2005).
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5.2.5 STATISTICS
The selection of Microsoft Excel 2007 for statistical analysis in study I and study II 
was based on this software’s advantage in graphic and table construction compared to 
other statistical packages. Excel is claimed to be untrustworthy as a statistical tool. A 
verification of statistical analysis in SPSS ver.19 confirms that p-values in Students t-
tests became slightly more significant from SPSS in both study I and study II. All 
other SPSS analyses on data in study I-III gave identical results as in Excel.
Generalized Estimating Equation (GEE) used in study II is a strong statistical analysis 
to estimate the parameters of a generalized linear model with an unknown correlation 
between outcomes. Since our novel study II on LLLT laser’s skin penetration time-
profile outcomes was unknown, this statistical method of analysis was suitable.
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5.3 FURTHER RESEARCH
Although some aspects of the research question were answered, several new questions 
have been raised:
- To what extent does the irradiation mode affect the skin penetration profile for 
infrared class 3B lasers?
- Which laser parameter(s) cause photobleaching effects in skin? 
(The phenomenon observed from the superpulsed 904 nm laser, in study II)
- When is optimal timing for initiation of LLLT after a trauma?
- Do tendons in young and old subjects’ respond differently to LLLT?
- How is the infrared-class-3B laser’s ability to penetrate human skin? 
(Human skin in different groups of age and skin colour).
Other questions which arose were:
- How are the histopathological findings in young compared to old rat tendons after 
a double trauma in the mini-guillotine?
5.3.1 FOLLOW-UP STUDIES 
As an extension of study II the time-profile for skin penetration for the irradiation 
mode chopped-pulsed (150 Hz) from the 810 nm, 200 mW MOP laser was 
investigated. The protocol from study II was used, and irradiation was done with the 
probe in skin contact (n=25) and not in skin contact (n=19).
- The skin penetration time-profile for chopped-pulsed irradiation was similar to the 
one for continuous irradiation: 22% (SD ±3.6) of MOP penetrated, and the 
penetration rate was stable over time.
Another follow-up study was done on timing the initiation of LLLT in acute Achilles 
trauma. The same dose as in study III was irradiated two hours after trauma. The study 
also included groups with a dose of 0.5 J half an hour after trauma and 0.5 J two hours 
after trauma. The same procedures as in study III was applied and tendon thickness on 
RTUS was the outcome measure. Groups consisted of 8 animals. The results were as 
follow:
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- The LLLT dose of 3 J was irradiated 2 hours after each trauma. 
On day three the tendon thickness was (incl. peritendon) 0.72 mm (SD ±0.11).
- The LLLT dose of 0.5 J was irradiated half an hour after each trauma. 
On day three the tendon thickness was (incl. peritendon) 0.84 mm (SD ±0.09).
- The LLLT dose of 0.5 J was irradiated 2 hours after each trauma. 
On day three the tendon thickness was (incl. peritendon) 0.70 mm (SD ±0.07).
These results indicate that timing the initiation of LLLT after acute tendon trauma is 
an issue to consider in clinical practice, as edema formation is more prominent from 
irradiation half an hour after trauma than from irradiation two hours after trauma.  
The irradiation dose also had effect on edema formation in rat Achilles tendons, where 
an irradiation dose of 3 J led to more edema formation than the 0.5 J dose. This 
indicates that 3 J might be too high a dose in acute trauma on small rodents. 
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5.4 CONCLUSIONS 
The endeavour of the three studies in this Thesis was to investigate some biophysical 
and biological effects from infrared class 3B lasers. 
The null hypothesis in study I on thermal effects in human skin from infrared class 3B 
lasers when irradiated with high doses was accepted, and the alternative hypothesis of 
no thermal effects was rejected.
The thermal effects in skin from typical WALT recommended LLLT doses for 
tendinopathies are negligible (<1.5°C) in light and medium coloured skin. However, 
higher LLLT doses delivered with a strong class 3B infrared laser (200 mW), are 
capable of inducing photothermal effects exceeding the thermal pain threshold for 
humans with dark skin. We found no significant differences in skin temperature 
between genders or between age groups during the laser irradiation sequence.
The null hypothesis in study II on a fraction of optical energy from infrared class 3B 
lasers penetrating rat skin was accepted, and the alternative hypothesis of no optical 
energy penetrate was rejected.
LLLT penetration through rat skin has been shown to provide sufficient optical energy 
at the sub-dermal level to influence pathological processes and tissue repair beneath 
the skin. The finding that energy from the superpulsed 904 nm laser penetrate 2-3
times better through rat skin than energy from the continuous 810 nm laser, 
corresponds well with results of LLLT dose analyses in systematic reviews of LLLT in 
musculoskeletal disorders. This may explain why the differentiation between these two 
laser types was needed in the clinical dosage recommendations of WALT.
The null hypothesis in study III on effect from a single LLLT dose in acute tendon 
trauma was accepted, and the alternative hypothesis of no effects from a single LLLT 
dose was rejected.
Irradiation with a dose of 3 J within half an hour after a tendon trauma embodies active 
integrant from LLLT in the ongoing processes in tissue beneath the skin. Optimal 
timing of LLLT administration after a trauma has not been debated in the literature. 
Our results show increased edema following LLLT irradiation administrated at half an 
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hour after trauma. This possibly indicate that half an hour after trauma is too early to 
initiate LLLT, or that recently LLLT-treated injured tendons may be more vulnerable 
than untreated tendons to a repeated injury. Another possibility is that the dose simply 
was too high. Future studies are needed to determine optimal timing of LLLT 
irradiation and optimal doses in acute tendon traumas. 
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Abstract
Objective: To investigate the effect of therapeutic infrared class 3B laser irradiation on skin temperature in
healthy participants of differing skin color, age, and gender. Background: Little is known about the potential
thermal effects of Low Level Laser Therapy (LLLT) irradiation on human skin. Methods: Skin temperature was
measured in 40 healthy volunteers with a thermographic camera at laser irradiated and control (non-irradiated)
areas on the skin. Six irradiation doses (2–12 J) were delivered from a 200mW, 810 nm laser and a 60mW, 904 nm
laser, respectively. Results: Thermal effects of therapeutic LLLT using doses recommended in the World As-
sociation for Laser Therapy (WALT) guidelines were insigniﬁcant; below 1.58C in light, medium, and dark skin.
When higher irradiation doses were used, the 60mW, 904 nm laser produced signiﬁcantly (p< 0.01) higher
temperatures in dark skin (5.7, SD 1.88C at 12 J) than in light skin, although no participants requested ter-
mination of LLLT. However, irradiation with a 200mW, 810 nm laser induced three to six times more heat in
dark skin than in the other skin color groups. Eight of 13 participants with dark skin asked for LLLT to be
stopped because of uncomfortable heating. The maximal increase in skin temperature was 22.38C. Conclusions:
The thermal effects of LLLT at doses recommended by WALT-guidelines for musculoskeletal and inﬂammatory
conditions are negligible (<1.58C) in light, medium, and dark skin. However, higher LLLT doses delivered with
a strong 3B laser (200mW) are capable of increasing skin temperature signiﬁcantly and these photothermal
effects may exceed the thermal pain threshold for humans with dark skin color.
Introduction
During laser irradiation, photons are transferred froma laser source to the human body. Photons are elemen-
tary particles with electromagnetic energy measured as
optical output power.1 Lasers with wavelengths in the near-
infrared and red spectrum of light are used in LowLevel Laser
Therapy (LLLT). Class 3B lasers used in LLLT have a mean
output power (MOP) ranging from 5 to 500mW.
Early reports regarding LLLT speculated that clinical ef-
fects were induced by increased temperature, although some
authors claimed that the effects of LLLT radiation were in-
duced by athermic physiological processes.2–3 More recently,
research suggests that LLLT effects are produced by photo-
chemical and photobiological processes.4–6 However, in or-
der to induce these therapeutic processes, light energy must
not be completely absorbed by the skin and needs to reach
subcutaneous tissue. Energy is transformed and stored as
heat during the process of absorption and the amount of
heating is inversely related to the penetration ability of the
light.
Interestingly, there is a lack of research into the thermal
effects from commonly used LLLT devices. A search with the
terms ‘‘thermal effect’’, ‘‘human skin,’’ and ‘‘laser’’ in
PubMed, Embase, Cinahl, and ScienceDirect (October 2009)
yielded no references for class 3B lasers.
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Skin color may affect absorption and skin temperature
during laser irradiation. Nussbaum7 found a tendency for
infrared LEDs (Light-Emitting Diodes) to produce higher
temperatures in human skin folds of participants with
dark skin than in those of participants with light skin.
Whether skin color inﬂuences skin temperature from
therapeutic infrared class 3B lasers has not been previously
investigated.
The structure, appearance, and biophysical properties of
human skin differ between individuals according to their
age, sex, and race. The ageing process leads to loss of colla-
gen and elastin ﬁbers, and reductions in the size of epider-
mal, dermal, and subcutaneous layers contribute to fragility,
loss of laxity, and a dry, ﬁne, wrinkled appearance of the
skin.8–11 Genetic and hormonal inﬂuences affect the sun-
sensitivity of skin. Females have greater sun-sensitivity than
males.12–13 After menopause, female skin thickness decreases
due to lower levels of estrogen.14–15
Skin color evolved in relation to the amount of sun irra-
diation in different parts of the world, with populations
living close to the equator having darker skin than popula-
tions living close to the poles. Human skin color is deter-
mined by type and amount of melanin in the skin16–19 which
has a central role in skin photoprotection.17,20 Thus, differ-
ences in skin color and properties are factors that may in-
ﬂuence absorption and production of heat in human skin
during LLLT irradiation.
Human skin temperature can be precisely and reliably
measured with thermographic cameras.21–25 The advan-
tages of thermographic cameras are that they are non-
invasive and can be used without being in contact with the
skin. The aim of this placebo-controlled study was to in-
vestigate the effect on skin temperature in healthy volun-
teers of differing skin color, age, and gender during
irradiation with doses recommended in the World Asso-
ciation for Laser Therapy (WALT) guidelines from two
commercially available therapeutic infrared class 3B lasers.
A second purpose was to investigate whether irradiation
from therapeutic infrared class 3B lasers can produce ther-
mal effects in human skin.
Ethical approval
The study was given ethical approval by REK Vest in
Norway (Ref.no: 091.08). Informed consent was obtained
from all participants.
Methods
Subjects
A sample of 40 healthy adult volunteers was recruited and
divided by gender, age, and skin color. Participants were
stratiﬁed according to skin color using Von Luschan’s chro-
matic scale,26 which ranks color from 1 (¼ lightest skin) to 36
(¼darkest skin). Three arbitrary categories were used: 1 to
15¼ ‘‘light’’ skin, 16 to 28¼ ‘‘medium’’ skin, and 29 to
36¼ ‘‘dark’’ skin. Participants were also stratiﬁed according
to age as under 40 years of age, between 40 and 60 years of
age, and over 60 years of age on the basis of changes in skin
optical properties.11, 27 Individuals with a history of skin
disease were excluded.
Instruments
Skin temperature was measured by a thermographic
camera (Flir System, ThermaCAM S65HS, Boston, MA) and
ancillary software (ThermaCAM Researcher Pro 2.8 SR-1).
This software includes tools to quantify the recorded tem-
perature. The camera measures temperatures with a preci-
sion of 50mK at 308C, and has an accuracy of 2% (Prod.
information). The Flir ThermaCAM S65HS used in this study
is calibrated once a year against a blackbody, emissivity
e¼ 0.99, distance¼ 1 meter. Calibration is based on the In-
ternational Temperature Scale (ITS-90)28 and performed at
the Swedish National Testing and Research Institute. Two
commercially available therapeutic lasers were used for ir-
radiation as follows: (a) 810 nm wavelength laser (Thor-DD,
London, UK), operated in continuous mode with a mean
output power (MOP) of 200mW, spot size of 0.0314 cm2 and
power density of 6.37W/cm2, (b) 904 nm wavelength laser
(Irradia, Stockholm, Sweden) operated in pulsed mode with
a peak power of 20W, pulse width of 200 ns (109 s), and
frequency of 700Hz; and with an MOP of 60mW, spot size of
0.0364 cm2, and power density of 1.67W/cm2.
Experimental procedure
In order to acclimatize skin temperature, participants re-
mained in the laboratory for 15 min before the experiment
started. Participants were instructed that during irradiation
they should report to the investigator (a) if they felt any heat
sensation in the irradiated area, and (b) if the heat sensation
became so uncomfortable that they wanted laser irradiation
to be ceased. During the experiment participants sat with
their hands on a towel placed on a table (Fig. 1).
Recommended irradiation doses according to WALT
guidelines are 2 J for 904 nm lasers and up to 6 J for 810 nm
lasers.29
Laser irradiation was performed on the proximal phalanx
of the index ﬁnger. A neighboring area on the proximal
phalanx of the same index ﬁnger was used as the control area
(Fig. 2).
FIG. 1. Laboratory setup. Thermographic camera placed
approximately 25 cm over the subject’s hand, with the par-
ticipant sitting at a table with both hands on a towel.
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One investigator ( JHD) operated the thermographic
camera, and another investigator ( JJ) administered laser ir-
radiation. Each experiment lasted 55 min, with a total of
13 measurements of skin temperature taken from each
participant. The ﬁrst measurement was taken before any ir-
radiation (i.e., baseline). This was followed by six measure-
ments during treatments with different doses of irradiation
from the 904 nm laser followed by six measurements during
treatments with different doses of irradiation from the
810 nm laser. The sequence of the doses was the same for
both lasers, as follows: (a) 2 Joule ( J)¼ 33 s duration from a
60mW, 904 nm laser and 10 s duration from a 200mW,
810 nm laser; (b) placebo¼ 33 s duration from an inactivated
60mW, 904 nm laser and 10 s duration from an inactivated
200mW, 810 nm laser (i.e., same duration as 2 J); (c)
6 J¼ 100 s duration from a 60mW, 904 nm laser and 30 s
duration from a 200mW, 810 nm laser; (d) 9 J¼ 150 s dura-
tion from a 60mW, 904 nm laser and 45 s duration from a
200mW, 810 nm laser; (e) 12 J¼ 200 s duration from a 60mW,
904 nm laser and 60 s duration from a 200mW, 810 nm laser;
(f ) placebo¼ 200 s duration from an inactivated 60mW,
904 nm laser and 60 s duration from an inactivated 200mW,
810 nm laser (i.e., same duration as 12 J). Placebo irradiation
was delivered using the same laser device as the active in-
terventions but the laser was not switched on. Participants
were not aware of this fact. During irradiation, the laser probe
was held in a position approximately 10 degrees from vertical,
and it was stationary in contact with one spot of skin over-
lying the dorsal side of the proximal phalange of the index
ﬁnger. Between each laser irradiation there was a 3 min pause.
Participants and the operator of the thermographic camera
were blinded to active or placebo treatment condition.
Thermography was recorded during the ﬁnal 5 s of each
irradiation dose and continued for 1 min after the end of
irradiation (i.e., a total of 1 min and 5 s). The maximum
temperatures from the irradiated area and a control area
ulnar to the irradiated area on the same index ﬁnger were
simultaneously registered by ThermaCAM (Fig. 2).
Main outcome measure
The difference in skin temperature between the irradiation
surface area and the control area was calculated for each
irradiation dose and each laser.
Statistical analysis
Microsoft Excel (Microsoft Ofﬁce Excel 2007) was used for
statistical analysis and graphics. Student’s pairwise T-tests
and ANOVA were used for comparison of statistical dif-
ferences with a signiﬁcance level set at p< 0.05. Pearson’s
correlation coefﬁcients were calculated to determine rela-
tionships between irradiation doses and skin temperature.
Results
Forty volunteers expressed interest in taking part in the
study, provided written consent, and were included (Table 1).
The baseline skin temperature after acclimatization was
30.78C (SD 2.8) in the proximal part of the index ﬁnger.
Placebo irradiation with a treatment time corresponding
to the 2 J conditions changed mean skin temperature in the
irradiated area by 0.98C (SD 0.7) for the 60mW, 904 nm
laser, and 0.28C (SD 1.2) for the 200mW, 810 nm laser.
Placebo irradiation corresponding to the 12 J treatment con-
ditions changed mean skin temperature by 0.48C (SD 1.2)
for the 60mW, 904 nm laser, and 08C (SD 1.1) for the
200mW, 810 nm laser. There were no signiﬁcant temperature
differences between the irradiated and control areas on the
index ﬁnger (no p value less than p< 0.05).
The tip of the laser probe was in skin contact during laser
irradiation, and the probe tip temperature was also mea-
sured immediately after irradiation. The probe tip tempera-
ture ranged from 31.88C (SD 1.8) to 32.68C (SD 2.0) for
the 200mW, 810 nm laser and from 30.18C (SD 2.2) to
33.78C (SD 3.4) for the 60mW, 904 nm laser for the irradi-
ation doses from 2 to 12 J (Table 2).
All participants completed the six irradiation doses with
the 60mW, 904 nm laser. Participants with light and medium
skin completed six irradiation treatments with the 200mW,
810 nm laser. However, 8 of 13 participants with dark skin
withdrew consent to continue the experiment because they
felt uncomfortable heating in the irradiated area with the
200mW, 810 nm laser. Two of these participants withdrew
consent during a 6 J irradiation dose (as recommended by
WALT), four withdrew consent during a 9 J irradiation dose,
and two withdrew during a 12 J irradiation dose.
Skin temperature at the time of withdrawal showed a
large variation between participants. The participant with
the highest measured increase in skin temperature (relative
FIG. 2. Thermographic picture (original picture is in color)
of the hand after laser irradiation with a dose of 12 joules.
Increasing whiteness corresponds to increasing temperature.
Table 1. Number of Participants Grouped
by Age and Skin Color
Skin color
Light Medium Dark Total
Under 40 years 5 5 7 17
From 40 to 60 years 4 7 4 15
Over 60 years 4 2 2 8
Total 13 14 13 40
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to the control area) during irradiation with the 200mW,
810 nm laser was a male with dark skin aged 45 years. The
skin temperature increased by 11.28C during a dose of 2 J,
and 22.38C during a dose of 6 J (irradiation was interrupted
by the investigators and he was not irradiated with doses of
9 and 12 J). The subject and experimental data related to
withdrawals are summarized in Table 3.
There was a positive correlation between increasing irra-
diation doses and increased skin temperature for both lasers
and all skin color groups (Pearson’s r¼ 0.98 – 0.99, with-
drawals omitted from analysis).
For light and medium skin, no signiﬁcant thermal effects
(p 0.16 for any comparisons) were observed when irradi-
ating at doses recommended in the WALT guidelines29 (i.e.,
2 J for 904 nm, and 6 J for 810 nm), with temperatures in-
creasing less than 1.58C regardless of laser type. However,
highly signiﬁcant increases (p< 0.0001) in skin temperature
were observed when irradiating dark skin: 6.18C (SD 3.2)
for the 2 J dose and 9.28C (SD 4.5) for the 6 J dose, using the
200mW, 810 nm laser. Also, irradiation with a 2 J dose using
the 60mW, 904 nm laser induced a lower but nevertheless
signiﬁcant (p¼ 0.043) increase in skin temperature, 1.98C
(SD 1.8), in dark skin (Figs. 3 and 4).
During the four active irradiation doses from LLLT, the
temperature change in dark skin was signiﬁcantly higher
than that in light skin for all irradiation doses, regardless of
laser type (p< 0.01). During these four doses, delivered with
the 60mW, 904 nm laser, the mean temperature difference
between the irradiated area and the control area ranged
from 0.18C (SD 1.0) to 4.08C (SD 1.3) in light skin, from
0.78C (SD 0.9) to 5.38C (SD 1.7) in medium skin, and from
1.98C (SD 1.8) to 5.78C (SD 1.8) in dark skin (Fig. 3).
During irradiation with the 200mW, 810 nm laser, thermal
effects were small in light skin, ranging from 0.38C (SD 0.8)
to 1.58C (SD 1.2), and moderate in medium skin, ranging
from 0.78C (SD 1.4) to 3.38C (SD 1.2). In dark skin, ther-
mal effects were substantial, from 6.18C (SD 3.2) to 9.88C
(SD 2.3) across doses from 2 to 12 J (Fig. 4).
When equivalent irradiation doses, of 6 J or more, were
administered to light and medium skin, there were larger
increases in skin temperature for the 60mW, 904 nm laser
when compared with the 200mW, 810 nm laser (p< 0.05)
(Table 4).
Due to the high withdrawal rate (62%) of participants in
the dark-skin group during irradiation with the 200mW,
810 nm laser, comparison of skin temperature for the two
lasers was problematic in this group.
Table 2. Low Level Laser Therapy Probe Tip
Temperature Immediately After Irradiation Doses
60 mW, 904 nm 200 mW, 810 nm
Mean SD Mean SD
Placebo 30.2 2.7 32.0 1.7
2J 30.1 2.2 31.8 1.8
6J 31.2 1.4 31.9 2.2
9J 32.8 2.9 31.8 2.9
12J 33.7 3.4 32.6 2.0
Table 3. Skin Temperature Thresholds at Withdrawal
Laser data Biographical data Temperature data
nm Dose Skin Sex Age Irradiated Control Difference
810 6 J Dark F 43 35.1 33.2 1.9
810 6 Ja Dark M 45 53.4 31.1 22.3
810 9 J Dark F 39 40.3 32.6 7.7
810 9 J Dark M 37 41.5 33.1 8.4
810 9 J Dark M 41 40.9 33.1 7.8
810 9 J Dark M 61 43.1 31.5 11.6
810 12 J Dark F 34 40.0 29.2 10.8
810 12 J Dark M 42 37.3 32.5 4.8
Mean 41.5 32.0 9.4
aParticipant completed irradiation with the 6 J dose (and did not start the 9 J dose).
FIG. 3. Doses in joules plotted against temperature change
in the three skin color groups during irradiation with the 60
mW, 904 nm laser (n¼ 40). The change in temperature was
deﬁned as the difference between temperatures in the irra-
diated area (laser spot) and a control area 1 cm ulnar on the
same index ﬁnger (error bars SD). *Signiﬁcant differences
between the light-skin group and the dark- and medium-skin
groups (p< 0.01). {Signiﬁcant differences between light- and
medium-skin groups and the medium- and dark-skin groups
(p< 0.05).
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In contrast to the results in light and medium skin, iden-
tical doses of laser irradiation resulted in signiﬁcantly higher
skin temperatures in dark skin (p 0.001) for the 200mW,
810 nm laser. Irradiation doses of 2 and 6 J with the 200mW,
810 nm laser induced a threefold increase in temperature in
dark skin when compared with the 60mW, 904 nm laser
(Figs. 3 and 4).
There were no signiﬁcant differences in skin temperature
between males and females during laser irradiation when
using doses at or above those recommended by WALT (no p-
value lower than p 0.24). Adjusting for skin color by re-
moving dark-skin data from the analyses did not affect this
result (Figs. 5 and 6).
There was a tendency toward higher skin temperatures
in the irradiated area in younger participants (under 40 years
of age) for both lasers, although comparisons with older
participants just failed to reach statistical signiﬁcance
(p 0.06). There was evidence that there were larger differ-
ences for higher doses with the 200mW, 810 nm laser than
for doses recommended by WALT, and that the differences
persisted when dark-skin data were removed from the
analysis (Figs. 7 and 8).
Discussion
In this study, we investigated the effects of irradiation
using two commercially available class 3B lasers on human
skin temperature for subjects of different skin color, age, and
gender. In the early days of LLLT, it was speculated that
treatment effects were of thermal origin and similar to heat
therapy.30 However, research in the 1980s supported claims
that doses used in clinical practice were too low to produce
noticeable thermal and biological reactions in the human
body.31 Subsequent research in the 1990s into the biophysical
properties of LLLT irradiation suggested that the therapeutic
effects of LLLT irradiation resulted from non-thermal
mechanisms.32 In recent years, more powerful class 3B laser
devices have arrived on the market, with laser manufacturers
claiming that ‘‘more powerful is better’’.
Thermoregulation of the skin is mainly controlled by the
hypothalamic nuclei. Heating of small areas of skin by con-
duction results in activation of skin thermoreceptors and
leads to the release of nitric oxide which acts directly on
blood vessels to dilate the vessels and thereby regulate body
temperature.33–36 Central thermoregulation acts to regulate
changes in larger areas of the body, such as the entire index
ﬁnger, and cannot result in local temperature differences like
those we found between the two measurement areas on the
proximal phalanx of the index ﬁnger.
We observed a consistent thermal effect of laser irra-
diation, which was strictly limited to the area of the irra-
diation spot. Skin temperature decreased to that of the
surrounding areas within 15 s after irradiation had ceased.
We interpret this effect as laser light absorption and subse-
quent heating of the skin, because it was clearly limited to
the area of irradiation and did not spread to the control site,
which was 1 cm away from the irradiated site on the same
index ﬁnger. We also observed an increase in skin temper-
ature which started proximally in the hand and then spread
to the ﬁngers in several participants following irradiation
with 6 J (100 s) or more from the 904 nm laser. Interestingly,
the temperature difference noted between the irradiation
FIG. 4. Doses in joules plotted against temperature change
in the three skin color groups during irradiation with the 200
mW, 810 nm laser (n¼ 40). The change in temperature was
deﬁned as the difference between temperatures in the irra-
diated area (laser spot) and a control area 1 cm ulnar on the
same index ﬁnger (error bars SD). * Signiﬁcant differences
between the dark-skin group and the medium-and light-skin
groups (p< 0.01). { Signiﬁcant differences between the me-
dium-skin group and the light-skin group (p< 0.05). a) Six
and b) eight of thirteen participants with dark skin withdrew
because of uncomfortable heating in the LLLT-spot area.
Table 4. Temperature Changes in Light and Medium Skin During Comparable Irradiation Doses
from Two Different Lasers
Light skin Medium skin
200 mW, 810 nm 60 mW, 904 nm t-test 200 mW, 810 nm 60 mW, 904 nm t-test
Irradiation dose Mean SD (8C) Mean SD (8C) (2-tailed) p value Mean SD (8C) Mean SD (8C) (2-tailed) p value
2 Joules 0.3 0.8 0.1 1.0 0.31 0.7 1.4 0.7 0.9 0.85
6 Joules 0.3 1.1 1.3 1.3 0.04a 1.4 1.2 2.5 0.9 0.01b
9 Joules 0.9 1.1 2.6 1.2 0.00b 2.2 1.0 3.9 1.0 0.00b
12 Joules 1.5 1.2 4.0 1.3 0.00b 3.3 1.2 5.3 1.7 0.00b
aSigniﬁcant (p< 0.05) differences during use of different lasers.
bSigniﬁcant (p< 0.01) differences during use of different lasers.
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spot and the control area was statistically signiﬁcant despite
the increase in background temperature across the entire
hand. We infer from these observations that laser irradiation
initiates central thermoregulatory mechanisms that affect
skin circulation in the skin surrounding the area of irradia-
tion. Slow-onset circulatory effects lasting more than 120 s
after irradiation have been reported in humans following 2
min of irradiation with 74mW, 810 nm laser37 and 20 min of
irradiation with a 30mW, 632 nm laser38 and in rabbits after
10 min with a 10mW, 904 nm laser.39 Evidence also suggests
that equal doses below 10 J delivered over a longer period of
time stimulates cell activity and modulates inﬂammation to a
greater extent than lasers with higher MOP using shorter
irradiation times.40–41
Thermal effects in the human skin need to reach a
threshold magnitude before they are perceived by individ-
uals. Recent studies have shown that there is spatial sum-
mation of warming sensation thresholds in the human hand
ranging from 35.48C (1.0) when large areas (9 cm2) are
heated to 42.38C (3.0) when small areas (2 cm2) are heat-
ed.42 During irradiation, heat could either stem from the
absorption of laser light or transfer of heat energy from the
laser probe to the skin by conduction as the laser probe heats
during production of the laser beam. Our measurements of
FIG. 5. Doses in joules plotted against temperature change
in males and females during irradiation with the 60 mW,
904 nm laser (n¼ 27). The change in temperature was deﬁned
as the difference between temperatures between the irradi-
ated area (laser spot) and a control area 1 cm ulnar on the
same index ﬁnger (error bars SD).
FIG. 6. Doses in joules plotted against temperature change
in males and females during irradiation with the 200 mW,
810 nm laser (n¼ 27). The change in temperature was deﬁned
as the difference between temperatures in the irradiated area
(laser spot) and a control area 1 cm ulnar on the same index
ﬁnger (error bars SD).
FIG. 7. Doses in joules plotted against temperature change
in the three age groups during irradiation with the 60 mW,
904 nm laser (n¼ 27). The change in temperature was deﬁned
as the difference between temperatures in the irradiated area
(laser spot) and a control area 1 cm ulnar on the same index
ﬁnger (error bars SD).
FIG. 8. Doses in joules plotted against temperature change
in the three age groups during irradiation with the 200 mW,
810 nm laser (n¼ 27). The change in temperature was deﬁned
as the difference between temperatures in the irradiated area
(laser spot) and a control area 1 cm ulnar on the same index
ﬁnger (error bars SD).
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the temperature of the laser probe tips immediately after
irradiation suggest that the probe tip was not responsible for
elevations in skin temperature; probe temperatures were
below 348C with doses of 12 J, and below 328C with doses
recommended by WALT.29 The thermal effects for doses
recommended by WALT were below the warmth sensitivity
thresholds for human skin for the respective lasers. This is
particularly important because the sensation of warmth can
compromise blinding of active and placebo laser units in
research studies.
Guinot12 found that female skin is more sun-sensitive
than male skin, but we did not ﬁnd any signiﬁcant differ-
ences in skin temperature between males and females
during infrared laser irradiation. Structures and entities of
the human skin do change with age and this change could
result in modiﬁed skin sensitivity to laser irradiation. Even
though there was a tendency to more heat production in
younger skin (under 40 years of age) than in older skin, we
did not ﬁnd signiﬁcant differences in skin temperature ac-
cording to age.
Our results showed that the heat induced in human skin
during LLLT irradiation is strongly related to skin color. Skin
temperature was higher at all irradiation doses for partici-
pants with dark skin than for those in other skin color
groups, regardless of laser type. Skin temperature differences
for the 60mW, 904 nm laser were moderate (about 48C)
during irradiation doses from 2 to 12 J, and increased ac-
cording to dose in a linear manner for all skin color groups.
While the dose-temperature proﬁle was linear for light- and
medium-skin groups with the 200mW, 810 nm laser, the
induced thermal effects were higher in darker skin. One
study using LEDs with an 840 nm infrared wavelength found
no signiﬁcant differences between participants with different
skin colors but there were few participants with the darkest
skin color in the sample and the power density for the LED
source was low and only 1–2% of the power density used in
the present study.7
The signiﬁcant heating of dark skin by the 200mW,
810 nm laser has implications for irradiation safety and
clinical practice. There was a three- to sixfold increase in skin
temperature in dark skin, reaching 42–438C, when compared
with light and medium skin. This temperature corresponds
to the threshold for painful thermal stimuli43 and was
achieved even at small laser irradiation doses.
Both lasers used in this study were classiﬁed as class 3B,
and their irradiation spot sizes were almost identical,
0.0364 cm2 (60mW, 904 nm) and 0.0314 cm2 (200mW,
810 nm). The authors see no reason why such a small spot
size difference would affect temperature to any appreciable
degree. Therefore, it is necessary to consider differences in
wavelengths, MOP, and irradiation mode (continuous vs.
pulsed) between the lasers as possible causes of the study
results. Infrared wavelengths penetrate human skin more
readily than red wavelengths.1, 44 However, there are only
minor differences (<20%) in rat skin penetration for wave-
lengths within the near-infrared spectrum, with 810 nm
penetrating slightly more than 904 nm wavelengths.45 The
observed differences in our study seem to exceed what can
reasonably be explained by wavelength differences. We
expected that the largest increase in skin temperature would
occur using the 200mW, 810 nm laser because its MOP is
approximately three times greater than the 60mW, 904 nm
laser, and it has a shorter irradiation time. However, skin
temperature increased more in light and medium skin
during irradiation with the 904 nm laser. It seems unlikely
that a physiological response such as more rapid removal of
excess heat should occur during and after irradiation with
the stronger 810 nm laser than the 904 nm laser. Future
studies are required to investigate in greater detail the in-
ﬂuence of MOP and irradiation mode (pulsed vs. continu-
ous) in heat production on human skin during laser
irradiation.
There is strong clinical evidence, reﬂected in the WALT
guidelines, that pulsed 904 nm lasers have lower optimal
dose ranges in musculoskeletal disorders than continuous
810 nm lasers, possibly because less energy is lost in the skin
barrier with the pulsed 904 nm laser.46 Our results from light
and medium skin may be seen as contradictory to this sug-
gestion because equal doses yielded signiﬁcantly higher skin
temperatures with the pulsed 904 nm laser than with the
continuous 810 nm laser.
During LLLT in which the thermal effect on the skin is
small, the irradiated energy facilitates other photoprocesses
in the local tissue. Infrared irradiation stimulates photobio-
logical reactions through photoacceptors that take part in
metabolic reactions in the cells.47–54 As the purpose of irra-
diation during LLLT is to reach structures beneath the skin
layers, the signiﬁcant thermal response in dark skin raises a
question as to whether sufﬁcient energy reaches subdermal
target tissue. Our results suggest that the 200mW, 810 nm
laser should probably not be used clinically with doses at or
above 6 J in persons with dark skin.
Conclusion
The thermal effects of LLLT at doses recommended in the
WALT guidelines for musculoskeletal and inﬂammatory
conditions are negligible (<1.58C) in light- and medium-
colored skin. However, at higher irradiation doses delivered
with a strong class 3B laser (200mW), LLLT is capable of
increasing skin temperature signiﬁcantly, and these photo-
thermal effects may exceed the thermal pain threshold for
humans with dark skin. The thermal effects in dark skin
were most pronounced during irradiation with the 200mW
MOP, 810 nm laser; 62% of participants withdrew because
of uncomfortable heating in the irradiated spot area. There
were no signiﬁcant differences between age groups or
between gender groups in skin temperature during laser
irradiation.
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Skin Penetration Time-Proﬁles for Continuous 810 nm
and Superpulsed 904nm Lasers in a Rat Model
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Abstract
Objective: The purpose of this study was to investigate the rat skin penetration abilities of two commercially
available low-level laser therapy (LLLT) devices during 150 sec of irradiation. Background data: Effective LLLT
irradiation typically lasts from 20 sec up to a few minutes, but the LLLT time-proﬁles for skin penetration of light
energy have not yet been investigated. Materials and methods: Sixty-two skin ﬂaps overlaying rat’s gastroc-
nemius muscles were harvested and immediately irradiated with LLLT devices. Irradiation was performed
either with a 810 nm, 200mW continuous wave laser, or with a 904 nm, 60mW superpulsed laser, and the
amount of penetrating light energy was measured by an optical power meter and registered at seven time points
(range, 1–150 sec). Results: With the continuous wave 810 nm laser probe in skin contact, the amount of pene-
trating light energy was stable at *20% (SEM – 0.6) of the initial optical output during 150 sec irradiation.
However, irradiation with the superpulsed 904 nm, 60mW laser showed a linear increase in penetrating energy
from 38% (SEM – 1.4) to 58% (SEM – 3.5) during 150 sec of exposure. The skin penetration abilities were sig-
niﬁcantly different ( p < 0.01) between the two lasers at all measured time points. Conclusions: LLLT irradiation
through rat skin leaves sufﬁcient subdermal light energy to inﬂuence pathological processes and tissue repair.
The ﬁnding that superpulsed 904 nm LLLT light energy penetrates 2–3 easier through the rat skin barrier than
810 nm continuous wave LLLT, corresponds well with results of LLLT dose analyses in systematic reviews of
LLLT in musculoskeletal disorders. This may explain why the differentiation between these laser types has been
needed in the clinical dosage recommendations of World Association for Laser Therapy.
Introduction
Lasers are used for a number of different purposes inmedicine. Class 4 surgical lasers are used to cut and de-
stroy biological tissue, whereas low-level laser therapy
(LLLT) is administered with weaker class 3B lasers and mean
output powers (MOP) < 500mW.1 The most commonly used
lasers in LLLT are gallium-aluminum-arsenide (GaAlAs) with
a wavelength of 810 nm ( – 50 nm) operating in continuous
output mode, and gallium-arsenide (GaAs) with a wave-
length of 904 nm superpulsed with high peak power pulses.
LLLT emerged as a treatment option in clinical practice
approximately three decades ago.2 After the initial upsurge,
LLLT gained a poor reputation because of a string of negative
research results being published. This picture has slowly
changed again as an increasing amount of evidence is point-
ing toward the existence of speciﬁc therapeutic windows for
LLLT. Several studies have found that anticipated optimal
doses yield signiﬁcantly better results in tendinopathies,3 os-
teoarthritis,4 and neck pain.5
The skin is the body’s external boundary in animals and
humans. Among other things, the skin serves as a barrier
against physical and chemical intrusions.6 The skin also
represents a barrier to applied physical energy from
1Department of Occupational Therapy, Physiotherapy, and Radiography; Faculty of Health and Social Science; Bergen University College;
Bergen; Norway.
2Physiotherapy Research Group, Department of Public Health and Primary Health Care, Faculty of Medicine and Dentistry, University of
Bergen, Bergen, Norway.
3Faculty of Engineering, Bergen University College, Bergen, Norway.
4Cardiovascular Research Group, Department of Biomedicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.
5Faculty of Education, Bergen University College, Bergen, Norway.
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electrophysical agents (EPAs), which represent one of the
four treatment pillars of physical therapy.7
EPAs are used to treat tissue such as muscles, tendons,
ligaments, and joint capsules. This makes the skin barrier of
particular interest for research on EPAs. Variation charac-
teristics in the biophysical ability to penetrate skin have di-
rect implications for the dosing of LLLT in clinical settings.
EPA therapy dosing has historically been based on clinical
experience, rather than solid scientiﬁc evidence from basic
research.8
The skin’s photoprotective properties, during epidermal
light reﬂectance and melanocytes light absorption, avoid
tissue injury caused by radiation from sunlight.9,10. The skin
penetration characteristics of ultraviolet and visible light, are
fairly well mapped in biophysical and dermatological liter-
ature. However, this literature provides only limited data
about the penetration ability of the most commonly used
infrared and near-infrared LLLT wavelengths in clinical
settings.
Biophysically, the ability of lasers to penetrate tissue is
dependent upon the laser’s wavelength. Light with a wave-
length range of 700–1000 nm is infrared and invisible, and
penetrates tissue better than light in the red wavelengths
(600–700 nm).11 Clinically, laser irradiation in skin ﬂaps has
shown that penetration increases linearly with wavelengths
from 450nm to 1030 nm.12 This was further supported by
results from a study of two different red laser wavelengths in
human skin ﬂaps, which showed that a wavelength of 675 nm
penetrated better than did a wavelength of 632.8 nm.13 Other
studies have reported similar ﬁndings with wavelength-
dependent penetration in animal tissue.14 These results cor-
relate well with another study showing that a greater amount
of energy penetrated rabbit skin with a wavelength of 904 nm,
than with a red wavelength of 632.8 nm.15
In a systematic review of LLLT studies on lateral epi-
condyle tendinopathies, Bjordal et al.3 found effective doses
from superpulsed 904 nm lasers to be signiﬁcantly lower
than effective doses from 632.8 nm lasers. Guidelines from
World Association for Laser Therapy (WALT) have also
differentiated between wavelengths. Typically, WALT rec-
ommends doses that are twice as high for lasers within the
780–860 nm wavelength range, than for lasers with a wave-
length of 904 nm.16 WALT guidelines doses are derived from
some 160 published randomized controlled LLLT trials. The
difference in energy dose can only partly be explained by
wavelength, which typically accounts for < 20% of the pen-
etration difference.12 However, a satisfactory causal under-
standing of the need for differentiated dosing is still lacking.
An aspect other than wavelength dependency is the mode of
operating the laser. GaAs lasers with 904 nm wavelength
operate with strong, short pulses (peak power 10–100W) in a
superpulsed mode with nanosecond or picosecond pulse
durations, whereas 780–860 nm GaAlAs lasers typically op-
erate in a continuous mode or with chopped pulses (peak
power < 0.5W). This feature has not been extensively ad-
dressed in the LLLT literature, and few studies have com-
pared continuous with pulsed and superpulsed irradiation.
In a recent article, Hamblin et al.17 searched the literature for
possible differences in therapeutic effects between those of
continuous and pulsed laser irradiation. Their conclusion
was that pulsed irradiation mode seems to be superior to
continuous mode. However, this result could also be caused
by differences in laser parameters other than irradiation
modes, as no head-to-head comparisons were performed
with equal doses. Moriyama et al.18 compared superpulsed
with continuous irradiation mode from 905 nm lasers in
acute knee inﬂammation in mice induced by Zymosan-A,
and found more pronounced upregulation of inducible nitric
oxide synthase (iNOS) from superpulsed irradiation mode.
They suggested that inﬂammatory pathway responses were
activated by different mechanisms in superpulsed and con-
tinuous irradiation modes.
The few existing LLLT studies that deal with penetration
issues have focused either on energy loss19,20 or on pene-
tration depth.13,15 In LLLT treatment, an irradiation dose is
typically administered during periods lasting from 20 to
30 sec up to a few minutes. No studies have yet investigated
the time-proﬁles for skin penetration of energy from LLLT
devices. With this perspective, we decided to perform a
study with two commonly used lasers in LLLT.
Aim
The aim of this study was to investigate the rat skin
penetration abilities of two commercially available LLLT
lasers during 150 sec of exposure.
Materials and Methods
Materials
Thirty-four matured male Sprague–Dawley rats weighing
250–300 g were housed with 3–4 animals together in indi-
vidually ventilated cages. Light cycles were kept at 12+/
12- h, with water and food ad libitum. The animals were
then euthanized and 62 skin ﬂaps (n = 62) overlaying the
gastrocnemius muscles on the hind legs were successfully
dissected free and irradiated within 3min after euthaniza-
tion. Six skin ﬂaps were discarded because of human errors
in the dissection procedure.
Instruments
The laser MOPwasmeasured with an Optical PowerMeter
System (Thorlabs Instruments, U.K.). The Optical Power
Meter System consists of a PM100 Display unit with sample
rate of 6Hz and accuracy of – 1%, and a S121B silicon sensor.
The S121B sensor input had an aperture with diameter of
O = 9.5mmwith an optical power range 500 nW–500mW and
an accuracy of – 5% (manufacturer’s speciﬁcation).
Two commercially available therapeutic lasers were used
for laser irradiation: (1) 810 nm wavelength laser (Thor-DD,
U.K.), operated in a continuous mode with MOP of 200mW,
spot size 0.0314 cm2, and power density of 6.37W/cm2
(manufacturer’s speciﬁcation); and (2) 904 nm wavelength
laser (Irradia, Sweden) operated in a superpulsed mode: Peak
power 20W, superpulsed width 100 ns (10 - 9 sec) with a fre-
quency of 6 kHz; and 60mW MOP, spot size 0.0364 cm2, and
power density 1.67W/cm2 (manufacturer’s speciﬁcation).
Experimental procedure, part 1
Step one: energy output measured directly. The two
lasers were tested for MOP during 150 sec of exposure with
no obstacles between the laser source and the Optical Power
Meter.
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Step two: energy output measured after penetrating a
plastic ﬁlm. The two lasers were tested for MOP during
150 sec of exposure with a transparent plastic ﬁlm between
the laser source and the Optical Power Meter.
Step three: energy output measured after penetrating
freshly harvested rat skin ﬂaps. with the probe in skin con-
tact. The animal was put into gas anesthesia (isoﬂurane,
Isoba), and then given 0.4mL intraperitoneal anesthesia
(Mebumal 50mg/mL). Hair was shaved from both hind legs.
Experimental procedure, part 2
Animals were then euthanized by cardiac arrest from a
1mL saturated potassium chloride solution.
The skin overlaying the gastrocnemius muscle was then
dissected free: distally from calcaneus, anteriolateral and
anteriomedial of the edge of the gastrocnemius muscle, and
proximal to the gastrocnemius muscle (Fig. 1).
The Optical Power Meter System was tuned to the same
wavelengths as the respective test lasers.
All skin ﬂaps were then irradiated in a sequential manner
with increasing exposure times for each laser.
For every skin ﬂap the measurement procedure started
with registering the lasers’ MOP directly into the Optical
Power Meter. A plastic ﬁlm was then placed over the sensor.
The skin ﬂap was then placed on the plastic ﬁlm and the
laser MOP was registered. During the exposure, the laser
probe was in full skin contact for 150 sec. The laser probe was
held in skin contact with slight pressure necessary to main-
tain the probe in a ﬁxed position. The therapist sought to
apply the same amount of pressure for all skin ﬂaps. Laser
penetration through the skin plus plastic ﬁlm was registered
at seven time points; immediately after being activated, after
10 sec, after 30 sec, and then every 30 sec up to 150 sec.
Step four (same procedure as in step three, but with
the probe not in skin contact). The laser probe was now
kept *1mm from the skin during LLLT irradiation.
Main outcome measure
The power was measured in mW without obstacles after
penetration through air, plastic ﬁlm, and rat skin ﬂap, and as
a percentage of the measured nominal MOP.
Statistical analysis
Statistical differences were calculated by Statistical Pack-
age for the Social Sciences (SPSS, v.19) using repeated mea-
sures ANOVA, generalized estimating equations(GEE), for
the whole sequence (measurements at 10 sec are omitted in
these calculations). Microsoft Excel (Microsoft Ofﬁce Excel
2007) was used for statistical descriptive analysis, Student’s
t-test p-value signiﬁcant differences, and graphs.
Ethical approval
This study was approved by the local animal laboratory
committee at the University of Bergen, Norway (Appl. No.
20102676).
Results
Step one (no obstacle, through air only)
The MOP from both lasers were stable during 150 sec of ex-
posure. The904nmlaser increasedMOPby 0.3mW(SEM–0.4),
whereas the 810nm laser reduced MOP by 9.8mW (SEM–1.9)
by the end of 150 sec of exposure (Table 1). The statistic GEE
estimated a slope of 0.25mW per 30 sec (95%CI: 0.07 to 0.42,
p<0.01) for the 904nm laser; and a slopeof -1.14mWper 30 sec
(95%CI: -1.44 to - 0.84, p<0.01) for the 810nm laser.
Step two (through plastic ﬁlm)
The plastic ﬁlm reduced MOP by 3.6%, or 2.3mW
(SEM – 1.2), on average from the 904 nm laser; and by 6.6%,
or 12.7mW (SEM – 1.0), on average from the 810 nm laser
(Table 1). The statistic GEE estimated a slope of 0.16mW per
30 sec (95%CI: - 0.10 to 0.42, p= 0.23) for the 904 nm laser;
and a slope of - 1.00mW per 30 sec (95%CI: - 1.49 to - 0.52,
p < 0.01) for the 810 nm laser.
Step three (through skin, probe in skin contact)
The two lasers had statistically different skin penetration
abilities. The percentage of energy penetrating skin from the
810 nm laserwas stable at* 20%ofMOP (ranging from 19.5%
[SEM – 0.6] to 20.4% [SEM– 0.6]) during the exposure period
(Table 1). The statistic GEE estimated slope was - 0.26% of
MOP per 30 sec (95%CI: - 0.35 to - 0.17, p< 0.01), whereas the
percentage of energy penetrating skin from the 904 nm laser
increased almost linearly during the exposure period, from
38.7% of MOP (SEM – 1.4) to 58% of MOP (SEM – 3.5) (Table
1). The statistic GEE estimated slope was 2.29% per 30 sec
(95%CI: 1.69 to 2.88, p < 0.01) for the 904 nm laser.
Comparing the percentage of MOP penetrating skin from
the two lasers, there were signiﬁcant (t-test, p < 0.01) differ-
ences at all measured time points (Table 1 and Fig. 2).
Step four (through skin, probe not in skin contact)
Both lasers showed the same trends of energy penetrating
skin as was the case with the laser probes in skin contact.
There were signiﬁcant (t-test, p < 0.01) differences in per-
centage of MOP penetrating skin from the two lasers at all
FIG. 1. A skin ﬂap, consisting of skin overlaying the gas-
trocnemius muscle.
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measured time points (Table 1), even though the slope of
increased penetration during processing time from the
904 nm laser was smaller than with the probe in skin contact.
The statistic GEE estimates a slope of 1.42% of MOP per
30 sec (95%CI: 0.82 to 2.03, p< 0.01) with the probe not in skin
contact. In percentages, the amount of energy penetrating
skin increased from 36.8% (SEM – 2.4) to 44.4% (SEM – 3.0)
during exposure (Table 1 and Fig. 2).
In skin contact versus not in skin contact
and probe’s shape
For the 810 nm laser, the amount of energy penetrating the
skin was slightly higher during irradiation than with the
probe in skin contact: The percentage of MOP was *24%
(ranging from 23.1% [SEM – 1.7] to 25.5% [SEM – 2.2]) during
the exposure period with the probe not in skin contact (Table
1 and Fig. 2).
The statistic GEE estimated slope was - 0.42% of MOP per
30 sec (95%CI: - 1.27 to 0.43, p= 0.33).
Irradiation with the laser probe in skin contact versus not
in skin contact resulted in a change in skin penetration for
both lasers. This change was most likely not attributed to
laser parameters, but to the different physical shape of the
two probe tips. The 904 nm laser probe has a protruding
convex lens, which squeezes the skin when the probe is in
skin contact. This will cause better penetration with full skin
FIG. 2. Percentage of mean output powers
(MOP) (– SEM) penetrating skin during
150 sec of irradiation, from the 904 nm
(60mW, superpulsed) laser and the 810 nm
(200mW, continuous) laser. Data are re-
presented with the laser probe in skin contact
and not in skin contact.
Table 1. Skin Penetration with LLLT Devices. Penetration Time-Proﬁle for Continuous 810nm
and Superpulsed 904nm Wavelength Lasers in a Rat Model
Exposure time (in seconds):
n 1 10 30 60 90 120 150
Direct (through air)
904 nm (mW) 5 64.7 64.3 64.2 64.4 64.6 64.8 65.0
(SEM– ) 0.2 0.2 0.5 0.4 0.4 0.4 0.4
810 nm (mW) 8 198.3 195.5 192.9 191.2 189.7 189.3 189.5
(SEM– ) 1.8 2.1 2.0 1.8 1.8 2.2 1.9
Through plastic ﬁlm
904nm (mW) 5 61.6 61.6 62.1 62.8 62.6 62.3 62.6
(SEM– ) 1.6 1.4 1.2 1.2 1.0 0.8 0.8
810 nm (mW) 7 185.5 182.8 180.1 178.4 177.4 176.5 175.7
(SEM– ) 0.7 0.8 1.0 1.2 1.2 0.9 1.3
Skin penetration (through plastic ﬁlm and skin)
Probe in skin contact
904 nm (% of MOP) 62 38.7 42.0 45.1 47.0 54.7 56.3 58.0
(SEM– ) 1.4 1.6 1.8 1.9 3.4 3.5 3.5
810 nm (% of MOP) 62 20.4 20.1 19.9 19.5 19.9 19.8 19.8
(SEM– ) 0.6 0.7 0.7 0.6 1.3 1.2 1.3
t-test ( p) 1.30E-19 1.01E-20 5.58E-21 1.74E-22 3.33E-11 2.70E-11 1.04E-11
Probe not in skin contact
904 nm (% of MOP) 15 36.8 37.6 38.6 41.2 43.6 43.4 44.4
(SEM– ) 2.4 2.8 2.8 3.2 3.3 2.9 3.0
810 nm (% of MOP) 9 25.5 25.5 25.5 24.3 24.4 23.1 23.7
(SEM– ) 2.2 2.0 1.8 1.8 1.8 1.7 1.5
t-test ( p) 3.91E-03 5.92E-03 3.10E-03 1.42E-03 0.46E-03 0.01E-03 0.44E-03
The mean energy output from two commercial LLLT-lasers, during 150 sec of irradiation: direct into an Optical Power Meter, through
plastic ﬁlm, and through plastic ﬁlm plus skin (with the LLLT-probe in skin contact and not in skin contact).
LLLT, low-level laser therapy; MOP, mean output powers.
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contact than with no skin contact. On the other hand, the
810 nm laser probe has a recessed ﬂat window. Here, the
metallic ring surrounding the lens will push skin underneath
the lens, which leads to less penetration with the probe in
skin contact than not in skin contact (Fig. 3).
Discussion
The skin barrier has been a major obstacle for EPAs since
they were introduced in the treatment of tissue pathology.21
Questions such as how deep can different energy forms
penetrate into the body, and what happens in terms of en-
ergy loss in this process has intrigued researchers for de-
cades. LLLT has poor penetration ability when compared
with other energy forms such as electromagnetic and ultra-
sound radiation. Nonetheless, it is important to emphasize
that the current study demonstrates that between 20 and 58%
of the energy delivered to the skin surface is penetrating the
rat skin barrier during LLLT irradiation. The important
conclusion is therefore that this residual energy should be
more than enough to reach the dose threshold for stimulat-
ing physiological and tissue repair processes.
The ﬁrst two steps of the experimental procedure devel-
oped as expected, showing that both lasers delivered stable
MOP, and that energy loss in a plastic ﬁlm was negligible
and stable. The time-proﬁles for skin penetration, during
150 sec of exposure, were, however, distinctly different for
the two lasers. For the 810 nm continuous laser, the pene-
tration ability stayed at the same level during 150 sec of
exposure, whereas the penetration from the 904 nm super-
pulsed laser increased in an almost linear manner during
150 sec of exposure. The higher skin penetration ability of the
904 nm superpulsed laser increased from + 18% initially to
+ 28% at 150 sec of exposure. This time-proﬁle of increased
skin penetration ability during exposure time has, to our
knowledge, never been demonstrated before. The pronounced
differences cannot be explained by different wavelengths
alone. According to studies investigating the ability of dif-
ferent wavelengths in light to penetrate skin, a difference of
1022 to 15%,23 could be expected between the wavelengths
800 nm and 900 nm. This leads us to speculate that the irra-
diation mode is the most likely source for the observed dif-
ferences in skin penetration. It has previously been suggested
that strong pulses may cause a photobleaching effect in the
skin barrier over time.24
In the research for identiﬁcation of possible LLLT dose-
response patterns, we suggested already in 2001 that the
different laser wavelengths and irradiation modes should be
classiﬁed in different categories.25 At that time, the differ-
entiation was governed more by minimizing uncertainty
than by solid evidence for these possible differences.
Our current ﬁndings contributes to a plausible explanation
for different effective doses from 904nm and 780–860 nm
lasers, found in clinical studies and reﬂected in WALT
guidelines.16 It can be illustrated by an example with two
60mWMOP lasers, that WALT recommendations of twice as
high doses for 810 nm lasers than for 904 nm lasers, as they
result in approximately equal amount of energy penetrating
the skin. A dose of 4 J from an 810 nm, 60mW, continuous
laser, takes 67 sec to deliver. The skin penetration rate with
the probe in skin contact is 20%. The cumulated amount of
energy penetrating skin is 0.8 J ( = 20% · 0.06W · 67 sec). The
delivering of a 2 J dose from a 904 nm, 60mW, superpulsed
laser, takes 33 sec. With the probe in skin contact, skin pen-
etration increase linearly from 38 to 45% during 30 sec of
exposure (percentages are in accordance with Table 1). The
amount of energy penetrating skin cumulates to 0.82 J
f¼ [(38% · 0:06WÞþ (½ · [45 38%]· 0:06W)] · 33 secg
In line with our currently demonstrated skin penetration
proﬁle, Castano et al.26 found long processing time from
superpulsed 810 nm lasers to be more effective than short
processing time in inﬂammatory rat knee arthritis. In
Castano’s study, all other irradiation parameters were held
equal.
In a study with LLLT intervention in induced arthritis in
mouse knees, Moriyama et al.18 found irradiation mode to
activate iNOS expression differently. They suggested differ-
ent mechanisms in activating the inﬂammatory pathway
response as an explanation to the signiﬁcant differences
found between superpulsed and continuous irradiation
mode from 905nm lasers. In perspective of our current
ﬁndings, the amount of energy penetrating skin from su-
perpulsed lasers is more than double the amount of energy
from continuous lasers, during 200 sec of exposure. These
circumstances could as well be part of the given reason.
This skin penetration proﬁle, with a linear increase in
amount of energy passing skin during an irradiated dose
from the superpulsed laser, points out processing time as an
interesting parameter in LLLT with superpulsed lasers.
In most clinical studies on animals, LLLT irradiation is
initiated hours after an injury or injection. In Moriyama’s
study with increased inﬂammatory reactions in mouse knees
after LLLT, the treatment from a superpulsed laser was
15min after induced inﬂammation. Similarly, we found
increased edema in rat Achilles tendon treated with 3 J from
a superpulsed laser within 30min after a blunt trauma.27
Whether these increased inﬂammatory reactions are caused
FIG. 3. Laser probe tip, the 904 nm laser with a protruding
lens (left), and the 810 nm laser with a folded up lens (right).
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by too early irradiation after induced injury, or whether the
amount of energy penetrating the skin gave a too high dose,
is unclear. We need further research on initiation of irradia-
tion and inﬂuence of irradiation mode to answer those
questions.
Conclusions
In clinical practice, the different skin penetration proﬁles
for superpulsed and continuous lasers will have some clini-
cal implications. In addition to different optimal doses as
reﬂected in WALT guidelines, the penetration proﬁle inﬂu-
ences skin temperature during LLLT treatment. We found
lower thermal effects in dark skin from 904 nm superpulsed
laser than from 810 nm continuous laser in one of our earlier
studys.28 This difference in thermal effects from these two
lasers can be explained by skin penetration proﬁle. The
percentage of energy absorbed in skin during processing
time is decreased for superpulsed lasers, whereas it is con-
stant for continuous lasers. In addition, 904 nm superpulsed
lasers have better skin penetration initially than do 810 nm
continuous lasers (Fig. 2).
Other critical features with the lasers, which are outside
the scope of this study, are to what degree output power
(peak value), power density (mW/cm2), and spot size (cm2)
inﬂuence skin penetration.
Other important questions, are ‘‘What happens to the skin
during LLLT irradiation?’’ and ‘‘Are results from lasers’ rat
skin penetration applicable to humans?’’ Few LLLT-studies
are concerned with sequelae in the skin during irradiation
aiming at tissues beneath the skin. This might be because of
the absence of side effects such as skin damage or ablation
from LLLT treatment.3 To the latter issue, the photoacceptor
processes from irradiation by near infrared light are believed
to be the same in all mammalian cells, catalyzed by cyto-
chrome c oxidase.29 Stratum corneum and skin thickness in
both rats30 and humans31 differs with body site. Most irra-
diation of the skin is absorbed or scattered in stratum cor-
neum of epidermis,32 and there is considerable similarity in
this skin layer thickness between rats30 and humans.31 On
the other hand, within the research areas of photodynamic
therapy and drug metabolisms, the degree of skin perme-
ability and percutaneous absorption differs between rats and
humans.33–36 Further histology investigations after single
and repeated LLLT irradiation of rat and human skin ﬂaps
are recommended to elucidate if the observed changes over
time in 904 nm penetration are irreversible or permanent.
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Abstract The aim of this controlled animal study was to
investigate the effect of low-level laser therapy (LLLT)
administered 30 min after injury to the Achilles tendon. The
study animals comprised 16 Sprague Dawley male rats
divided in two groups. The right Achilles tendons were
injured by blunt trauma using a mini guillotine, and were
treated with LLLT or placebo LLLT 30 min later. The injury
and LLLT procedures were then repeated 15 hours later on
the same tendon. One group received active LLLT (1=
904 nm, 60 mW mean output power, 0.158 W/cm2 for 50 s,
energy 3 J) and the other group received placebo LLLT 23
hours after LLLT. Ultrasonographic images were taken to
measure the thickness of the right and left Achilles tendons.
Animals were then killed, and all Achilles tendons were
tested for ultimate tensile strength (UTS). All analyses were
performed by blinded observers. There was a significant
increase in tendon thickness in the active LLLT group when
compared with the placebo group (p<0.05) and there were
no significant differences between the placebo and unin-
jured left tendons. There were no significant differences in
UTS between laser-treated, placebo-treated and uninjured
tendons. Laser irradiation of the Achilles tendon at
0.158 W/cm2 for 50 s (3 J) administered within the first
30 min after blunt trauma, and repeated after 15 h, appears
to lead to edema of the tendon measured 23 hours after
LLLT. The guillotine blunt trauma model seems suitable for
inflicting tendon injury and measuring the effects of
treatment on edema by ultrasonography and UTS. More
studies are needed to further refine this model.
Keywords LLLT. Acute injury . Rat Achilles .
Ultrasonographic imaging . Edema . Ultimate tensile
strength
Introduction
Animal models are commonly used in tendon disorder
research. They have the advantages of incorporating
invasive evaluation techniques, and the possibility for
detailed tissue examination and analysis of biochemical
substances. These models may be useful in reproducing
some aspects of human tendon disorders because in animal
models it is easier to control single factors.
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In experimental studies on animal tendons, partial or
total surgical tenotomy is the most commonly used method
for inducing injury [1–8]. Another, nonsurgical, method of
injury induction has been introduced in a few studies of
tendons in small rodents [9–11]. In this model, an external
blunt trauma is inflicted by a mini guillotine where a block
falls down from a fixed height and crushes the tendon.
After such an injury in a mini guillotine, significant
histological changes have been found when compared to
healthy tendons [9–11]. However, other relevant outcome
measures such as edema and the tendon’s ability to
withstand load, have not yet been investigated.
The primary purpose of tendons is to transmit tensile
load from muscles to bone insertions. Their biomechanical
properties can be measured by their ultimate tensile strength
(UTS). UTS is an outcome measure of a the tendon's ability
to tolerate tensile load and elongation [12]. In two studies
on rat tendons where UTS was used as an outcome
measure, healthy rat Achilles tendon had UTS values of
42.5±5.5 N (mean±SD) [13] and 48±11.0 N [14].
Low-level laser therapy (LLLT) is considered to act in a
biomodulatory manner through light absorption by photo-
receptors, which stimulates cells and modulates inflamma-
tory processes [15–19]. Studies performed in a variety of
different pathological conditions including injured animal
tendons are frequent in the LLLT literature. In most of these
LLLT studies, tendons were treated daily for 3 to 21 days
[1–5, 9, 11]. Observed histopathological changes in tendons
receiving LLLT include increased collagen production [1],
improved collagen bundle organization [2–4, 11], and an
increased number of small blood vessels [9]. Some studies
have investigated the effect of LLLT within the first 24 h
after an acute inflammation. After induction of inflamma-
tion followed by three or four LLLT sessions, tissue
receiving LLLT exhibited reduced concentrations of in-
flammatory markers and cells compared to no-treatment
controls [20, 21].
In the clinical setting tendon disorders are common.
Tendon loading seems to be a risk factor for developing
tendon disorders, particularly in the upper extremities
among manual workers [22] and in the lower extremities
among athletes [23]. Acute tendinitis may occur after
unfamiliar repetitive movement, friction and pressure
during tendon loading, and is often seen in the Achilles
tendons of military recruits after long marches [24].
Chronic tendinopathies have a more complex etiology and
manifestation, and development of chronic tendinopathies
may be gradual and less clearly associated with tendon
loading episodes. Age seems to be of importance, and
partial or complete tendon ruptures are strongly correlated
with age [25]. Developing experimental animal models
which accurately mimic the clinical situation in chronic
tendinopathies is a challenge, and the ultimate experimental
model has yet to be found [26]. Soslowsky et al. [27]
developed a rat model of repetitive loading of the supra-
spinatus in treadmill running, but some aspects including
genetics and the influence of pre-experimental structural
tendon defects, have not been catered for. Another, as yet
unused, possibility for mimicking tendinopathies is to
repeat infliction of injury by blunt trauma.
During the last two decades, ultrasonographic imaging
(US) has become a popular diagnostic tool for assessment
of musculoskeletal disorders [28]. US is reported to have
high accuracy in diagnosing disorders in superficial human
tendons [28–30].
The aim of this study was to investigate the effects of
LLLT administered 30 min after an Achilles tendon injury
inflicted by a mini guillotine. The outcome was measured
as tendon edema on US and tendon tensile strength.
Method
Animals
The study animals comprised 16 male rats (Sprague Dawley
SD M; Taconic Europe, Denmark) weighing 250–300 g,
which were divided in two groups. The rats were housed four
and four in individually ventilated cages under a light cycle of
12 hours light/12 hours dark, in an atmosphere of humidity
55% and a temperature range of 20–22°C, and with water and
food ad libitum.
Instruments
Mini guillotine The mini guillotine comprised a block
weight of 200 g with a blunt edge 2 mm wide that was
dropped from 20 cm guided by supports (Fig. 1).
Laser The laser emitted radiation at a wavelength 904 nm
(Irradia, Sweden) and was operated in pulsed mode. The
peak power was 20 W, the pulse width 200 ns and the
frequency 700 Hz. The mean output power was 60 mW, the
spot size 0.38 cm2 and the power density 60 mW/0.38 cm2
(=0.158 W/cm2). Two identical single diode laser probes
were use, one with active laser and the other an inactive/
placebo probe. Irradiation was applied for 50 s. Thus 3 J
was delivered from the active laser.
Ultrasonography The US instrument was a GE Logiq e
(GE Healthcare, Minneapolis, MN) with a 12 MHz linear
probe.
Material test system A servohydraulic testing machine (MTS
810; MTS,Minneapolis, MN) equipped with a calibrated load
cell of 500 N and a position transducer of 100 mm was used.
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The deformation rate was 0.25 mm/s. The load and
deformation data were sampled continuously during the test.
Experimental procedure
One investigator (J.M.B.) labeled one laser probe with blue
tape and the other with yellow tape. The code for active and
placebo probes were not disclosed until the statistical
analysis was done. The laser probe output was then
measured to determine which probe had been the active
one. The main outcome measures were tendon thickness
(including the peritendon) as measured on ultrasonographic
images and UTS. The study was approved by the local
animal laboratory committee at the University of Bergen
(application no. 20102676).
The experimental procedure (Fig. 2) was carried out in
six steps:
1. The animal was anesthetized with isoflurane (Isoba)
using an Isotec vaporizer. Under anesthesia, the
animal’s right ankle was positioned in full dorsal
flexion in the mini guillotine such that the edge of the
block hit just proximal to the insertion on the calcaneus
(Fig. 1). This procedure was carried out by J.J. After
injury, the animal’s tail was marked to distinguish it
from others in the cage, and was put back into the cage.
All animals in each group were subjected to this
procedure.
2. Half an hour after injury, the animal was again
anesthetized and the injured area was treated for 50 s
with either active (3 J) or placebo LLLT delivered to
one single point (performed by J.J.). A new mark was
put on the tail. This treatment procedure was repeated
in all eight animals in each group.
3. The next day, 15 h after the first injury, the same area of
the right Achilles tendon was again injured using the
guillotine according to the procedure in step 1 and half
an hour after later the area was treated for 50 s with
LLLT according to the procedure in step 2. This
procedure was performed by J.J.
4. On day three, 23 h after the second injury, US was
performed bilaterally on the right and left Achilles
tendon (carried out by S.H.). The imaging depth was
set to 2 cm, with three focus areas around the first
centimeter (Fig. 3). The animal was anesthetized and
the Achilles tendon area was scanned in both the
longitudinal and transverse planes, two images in both
planes. The longitudinal plane was scanned with the
whole length of the Achilles tendon in the image.
Tendon thickness (including peritendon) in the longi-
tudinal plane images was measured from the os
calcaneus up to the deeper layer of the skin (Fig. 3).
When scanning the Achilles tendon and the adjacent
structures in the transverse plane the probe was moved
distally from the knee until it met the os Calcaneus, and
images were acquired in this position. The thickness in
the transverse plane was measured as the vertical distance
within the anterior and posterior border of the peritendon.
In the statistical analyses the averages of the measure-
ments from two US images were used. Each animal’s tail
was marked after the US scan was complete.
5. The animals were anesthetized 2 h later and given
0.4 ml intraperitoneal anesthetic (Mebumal 50 mg/ml;
1 ml contains 54.9 mg pentobarbital sodium, 400 g
propylene glycol, 150 mg strong alcohol and distilled
water to 1 ml). The animals were killed by injection of
1 ml saturated potassium chloride solution to cause
cardiac arrest. The skin overlying the right gastrocne-
mius muscle was released from the calcaneus to the
proximal part of the triceps surae muscle. The Achilles
tendon was then released with scissors, and the muscle
fibers were removed from the tendons with a scalpel.
Water containing 9% sodium chloride was sprayed over
the tendon. The tendon was put into a small plastic bag,
labeled and stored in a refrigerator at 4°C. The same
A)         B) 
Fig. 1 a Mini guillotine with rat positioned for Achilles injury. b
(insert) Close-up of the tendon crush location
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procedure was used for the left Achilles, and on all
animals. This was carried out by J.J.
6. The tendons were subjected to UTS testing 3 h after
release. The proximal end of the Achilles tendon was
sprinkled with 250 μm alumina powder before it was
gripped in a clamp to prevent sliding. A special conically
designed grip for the distal end of Achilles tendon was
used. In this grip the os calcaneus was used as a plug to
obtain the optimal tendon grip [31, 32] (Fig. 4). The
maximal load for each tendon at failure was recorded.
The procedure was performed by OJ.L. and N.R.G.
Statistical analysis
Differences between injured right Achilles and healthy left
Achilles tendons were analyzed using a paired t-test, and
differences between groups were analyzed using the t-test
in SPSS (version 18) from Microsoft.
Results
The thickness of the injured right and the healthy left
Achilles tendons in the longitudinal US images were
significantly different (p<0.05) in the active LLLT group
(Table 1), but were not significantly different in the placebo
LLLT group (p=0.35; Table 1). The mean thickness of the
injured right Achilles tendon was 0.93±0.03 mm in the
active LLLT group and 0.73±0.07 mm in the placebo LLLT
group, and the mean thickness of the healthy left Achilles
tendon (including the peritendon) was 0.69±0.07 mm and
0.70±0.10 mm, respectively.
In the transverse US images the difference between the
injured right and the healthy left Achilles tendon was
Fig. 2 The experiment time schedule
Fig. 3 Longitudinal US images
with tendon thickness
measurements. Active LLLT
group 2) left and right Achilles
tendon (rat 5), 0.70 mm and
0.93 mm, respectively
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significant (p<0.05) in the active LLLT group (Table 1),
but was not significant the placebo LLLT group (p=0.16;
Table 1). The mean transverse thickness of the injured right
Achilles tendon was 0.70±0.10 mm in the active LLLT
group and 0.63±0.14 mm in the placebo LLLT group. The
mean thickness of the healthy left Achilles tendon in the
two groups was 0.51±0.07 mm and 0.57±0.07 mm,
respectively.
There were no significant differences in UTS between
the injured right and healthy left Achilles tendon in the
active LLLT group or in the placebo LLLT group (Table 1).
The mean UTS in the injured right Achilles tendon was
51.11±9.77 N in the active LLLT group and 57.64±7.80 N
in the placebo LLLT group. The mean UTS in the healthy
left Achilles tendon was 53.94±9.80 N in the active LLLT
group and 59.66±11.86 N in the placebo LLLT group.
Discussion
Biomechanical test methods are commonly used in the
evaluation of surgically induced tendon injuries [31–33].
The UTS values are fairly low during the first 2 weeks after
tenotomy and previous studies have avoided UTS testing in
models where tendons are not seriously weakened by sharp
trauma. Measuring UTS after tendon injury induced by a
mini guillotine has to our knowledge not previously been
reported in the literature. After a standardized injury in a
mini guillotine, rat tendons show histopathological changes
[9–11]. However, we found no differences in the biome-
chanical properties as revealed by UTS between injured and
healthy rat Achilles tendons 1–2 days after injury. Similar
UTS values have been found in rat Achilles tendons
subjected to carrageenan injection [34].
A major technical challenge in UTS testing of healthy rat
Achilles tendons is to obtain a reliable, nonsliding grip of
the proximal end of the tendon. We have found only two
studies investigating UTS of healthy rat Achilles tendons,
possibly because grip slippage before the tendon ruptures.
In this study we succeeded in developing a grip with a
combination of rolling the tendon around conical anchors,
and the application of alumina powder to enhance friction.
Thus, grip-induced rupture was avoided, and most tendons
ruptured a few millimeters from the distal grip with forces
up to 75.2 N.
The standard deviation of the UTS of healthy rat
Achilles tendons is ±10 N (present results, and references
[14] and [34]) and the difference between healthy and
injured tendons is typically 2–3 N. Thus, in future studies
with the mini guillotine and UTS, the injury procedure will
have to be refined in order to weaken the tendon
sufficiently to obtain significant decreases in UTS values
after injury.
An irradiation dose of 3 J is commonly used in clinical
practice in human inflammatory conditions and was taken
from the dose recommendations of the World Association
for Laser Therapy (WALT) [35]. In retrospect, this may
Fig. 4 A rat Achilles tendon at the moment of rupture during UTS
testing
Table 1 Thickness (means±SD) of the injured and healthy Achilles tendons and mean differences in thickness as measured by US and UTS (n=8)
Group View Tendon thickness (mm) 95% CI p value
Right (injured) Left (healthy) Difference (injured−healthy)
US Placebo LLLT Longitudinal 0.73±0.03 0.70±0.10 0.03±0.09 −0.04 to 0.11 0.35
Transverse 0.63±0.14 0.57±0.07 0.07±0.12 −0.03 to 0.17 0.16
Active LLLT Longitudinal 0.93±0.03 0.69±0.07 0.24±0.07 0.18 to 0.30 0.00*
Transverse 0.70±0.10 0.51±0.07 0.19±0.10 0.10 to 0.27 0.00*
UTS Placebo LLLT 57.64±7.80 59.66±11.86 −2.02±15.09 −14.64 to 10.60 0.72
Active LLLT 51.11±9.77 53.94±9.80 −2.83±10.76 −11.82 to 6.16 0.48
*p≤0.05.
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have been too high for rat Achilles tendon pathology.
Optimal irradiation doses from 904-nm lasers in rat muscles
seem to be closer to 1 J. In a new study with LLLT, doses
of 0.1, 0.3, 1.0 and 3.0 J were used to prevent skeletal
muscle fatigue and possible muscle damage. All irradiated
groups except the group irradiated at a dose of 3.0 J had
significantly lower post-exercise creatine kinase activity
than the control group immediately after the contraction
tests [36]. If these doses translate to rat Achilles tendons, it
could explain the nonsignificant differences, but not the
increased edema observed in the active LLLT group.
In the current study there was an interval of 15 h between
the two LLLT irradiations. There are very few studies in
which there was an interval of less than 24 h between
irradiations. Thus, we cannot rule out the possibility that an
interval of 15 h was too short and resulted in negative effects
of LLLT. This is clearly an area where more research is
needed. A more likely explanation for the increased edema in
the active LLLT group could be an indirect consequence of
symptomatic pain reduction from LLLT leading to increased
activity causing more edema [37, 38]. Reduced pain
sensation from the injured tissue could promote physical
activity, and this may result in a temporary increase in edema
at the site of injury during the 23 h between the LLLT
irradiation session and the US examination [39].
The timing of LLLT irradiation in the acute phase of
inflammation is seldom discussed in the literature, but it can
be crucial for achieving positive effects. In some animal
studies, LLLT treatment has been found to reduce edema,
and is typically been measured 4 hours after injury [40–42].
Thus, we did not expect to find an increase in edema after a
single LLLT treatment 30 min after injury. We speculate
that the unexpected differences between the results may be
explained by differences in study design. Scrutiny of the
design of other similar LLLT studies showed that LLLT has
mainly been administered later than 30 min after injury [42]
and/or that the treatment procedure included more than a
single LLLT session [2, 3, 9, 21, 40, 41].
It is known that LLLT energy acts on biological
processes [43]. We therefore considered the cascade of
responses in the acute phase of inflammation, and in
particular which processes are dominant in the first half
hour. The immediate response in the innate immunity after
an injury is activation of signal transduction mechanisms.
Immediate genes activated within the first half hour of
inflammation are mainly transcription factors [44, 45].
Among these expressed cytokine gene is mitogen-activated
protein kinase (MAPK) [46]. Three well-characterized
subfamilies of MAPK are stress-activated protein kinases/
c-Jun N-terminal kinase (JNK), p38 mitogen-activated
protein kinase (p38) and extracellular regulated protein
kinases (ERK) [44, 47, 48]. Peak times for kinases have
been established for JNK, p38 and ERK in tendon cells,
smooth muscle cells, endothelial cells and cardiac fibro-
blasts. JNK, p38 and ERK increase rapidly, and they reach
a maximum within 10 to 30 min [49–52]. The impact of
JNK, p38 and ERK on edema has been investigated in
rodent paw models and brain injury models using inhibitors
for JNK, p38 and ERK, respectively. Tested selectively, all
these inhibitors reduce the development of edema, and
consequently JNK, p38 and ERK may increase edema
development [53–56].
The effect from LLLT (632.8 nm, 4.5 mW) on JNK, p38
and ERK has been investigated in skeletal muscle cells.
LLLT does not increase JNK and p38 activation or protein
expression, but LLLT induces protein translation through
ERK pathways [57, 58]. Perhaps the unexpected increase in
edema development in the LLLT group in our study can be
explained through a stimulation of the ERK pathway. But
this is speculative as we did not measure any of the
outcomes needed to confirm or refute this theory.
We also explored studies with LLLT irradiation within
the first half hour after injury (injection or surgery) with
regard to edema development. In a previous study by
members of our research group [40], different timing
protocols for LLLT (650 nm) were used. Carrageenan was
injected into rat paws and edema was measured 1 to 4 h
later. The main conclusion was that LLLT has an antiin-
flammatory effect in most cases, but one group treated with
LLLT had developed increased edema 10 min after
injection compared to controls.
Some clinical studies in dentistry have evaluated the
effect of LLLT on edema development immediately after
surgery [59–64]. The timing of LLLT administration was
not explicitly reported, but in two studies report the
duration of surgery was 19 min [63, 64]. In one study,
LLLT given immediately after surgery was found to have
increased edema at 3 days, but not at 7 days [62]. Two
studies with adequate doses found reduced edema [63, 64].
In three studies LLLT doses did not meet the WALT dose
recommendations for LLLT. One study used a scanning
mode for application of the laser beam [61], and the other
two used doses that were too low (<1 J) [59, 60].
Even though the results regarding edema development in
studies in which LLLT was used within the first half hour
after injury are arbitrary, it is not unlikely that LLLT
irradiation within the first half hour after an injury will
temporarily increase edema. This finding has important
clinical implications, as it has been an open question as to
when is the earliest time-point for effective LLLT admin-
istration. Interestingly, in some studies LLLT has been
administered before muscle damage or the onset of
inflammatory process with good results on other outcome
measures [36, 65]. This indicates that the negative effect on
edema development is restricted to inflamed tissue and the
first half hour after the onset of inflammation.
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Our decision to use the mini guillotine model was an
attempt to mimic a tendon disorder with inflammatory
components. Signs of inflammation are present in acute and
mild tendinopathies [66, 67]. In previous studies using the
mini guillotine injury method in rodents, the injured
tendons have shown inflammatory reactions [9–11]. The
significant increase in thickness of the injured tendons
supports the suitability of the mini guillotine model for
causing Achilles tendinopathy in the rat. The mini
guillotine model has the advantage of being easier to use
than overuse models such as the treadmill running model of
Soslowsky et al. [68]. None of these models involves
penetration of the skin and therefore they avoid the risk of
infection during the injury procedure. The surgical proce-
dure of tenotomy does introduce a risk for infection, and it
may also be questioned as to how relevant this model for
investigation of tendinopathies.
The use of animal models in research on human
tendinopathies has its limitations. There are obvious
anatomical differences between bipeds and quadrupeds.
This affects the validity of using animal models to study
tendinopathies, and limits extrapolation of the findings in
animal studies to human tendinopathies. Whether effec-
tive laser parameters in small rodent models can be
extrapolated to humans remains uncertain and additional
clinical studies in humans to verify or repute the findings
are called for.
Conclusion
Laser irradiation at 0.158 W/cm2 for 50 s (3 J) administered
within the first half hour after two blunt trauma injuries15 h
apart appeared to increase edema in the rat Achilles tendon
measured at 23 h after LLLT.
The UTS of the rat Achilles tendon was not decreased
significantly after two blunt traumas inflicted by a mini
guillotine. This experimental model appears useful for
investigating the optimal timing and effect of therapies in
acute tendon injuries. In this model, edema can be
reliably measured by US, and tendon UTS can be
reliably tested in both healthy and weakened rat Achilles
tendons. There is a need to further refine the experimen-
tal procedure to achieve a weakening of the rat Achilles
tendon. Further studies with this model should include
variations in the intervals between traumas, the timing of
treatment, the number of LLLT sessions and the power
densities.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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